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ABSTRACT 
Aims: 
To investigate the remineralising potential of toothpastes with different formulations of 
fluoride (F): amine fluoride (AmF), sodium monofluorophosphate (MFP), sodium fluoride 
(NaF) and stannous fluoride (SnF) on artificial subsurface caries lesions in vitro. A 
secondary aim was to investigate the remineralising potential of toothpastes containing 
sodium fluoride (NaF) formulation at different F concentrations (500, 1000, 1450, 2800 
and 5000 ppm F) on artificial subsurface caries lesions in vitro. 
Materials and methods: 
Bovine enamel slabs were subjected to a pH cycling model after 2 weeks of immersion in 
a demineralisation buffer, to produce subsurface enamel lesions. The pH cycling regime 
ran for 28 days. Enamel subsurface lesion images were taken using a Quantitative Light-
Induced Fluorescence (QLF) system under controlled conditions at baseline and 
endpoint of the experiment. All ﬂuorescence images were examined with analysing 
software (QA2 version 1.16; Inspektor Research Systems). 
Results: 
For the different F compounds, significant (p < 0.05) remineralising potential was 
observed for the NaF, SnF and MFP groups in descending order. Lesion remineralisation 
for the AmF and F-free groups was not significant. As for the different fluoride 
concentrations, all fluoride concentrations showed significant (p < 0.05) remineralisation 
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potential when compared to the 0 ppm F control group, but no significance was found 
between groups. 
Conclusions: 
From the results of phase A of this in vitro study, it was concluded that: A statistically 
significant remineralisation of enamel subsurface lesions in comparison with the baseline 
was found in all groups except the AmF group. Furthermore, NaF toothpaste had the 
highest remineralising potential on artificial subsurface carious lesions in vitro, followed 
by SnF then MFP, while AmF was less than the F-free toothpaste. 
The results of phase B of this in vitro study, concluded that: A statistically significant 
remineralisation of enamel subsurface lesions in comparison with the baseline was found 
in all groups. However, there was no difference in the effect of toothpastes with sodium 
fluoride (NaF) formulation and different concentrations (500, 1000, 1450, 2800, and 5000 
ppm F) on remineralisation of artificial subsurface carious lesions in vitro, and no 
apparent dose response was present related to the concentration of fluoride.
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Chapter 1 REVIEW OF LITERATURE 
1.1 Dental caries 
Dental caries is defined as a transmissible disease process that causes localised 
destruction of susceptible dental hard tissues by acidic by-products from bacterial 
fermentation of dietary carbohydrates (Featherstone, 2008). 
 Dental caries is a chronic, reversible, preventable and multifactorial  disease that occurs 
due to microbiological shifts in the plaque biofilm. Dental caries is affected by salivary 
flow and composition, fluoride exposure, frequency of dietary sugar consumption, and 
preventative behaviours such as tooth brushing (Selwitz et al., 2007). 
1.1.1 Pathogenesis of dental caries 
Interaction between acid producing bacteria (mainly Streptococcus mutans, 
Streptococcus sobrinus and Lactobacillus Spp) and fermentable substrate over a period 
of time, with the presence of host factors including teeth and saliva leads to an 
imbalance of the physiological equilibrium between tooth minerals and oral microbial 
biofilms, which in turn produces dental caries (Scheie and Petersen, 2004).  
Acid produced as a by-product of fermentation causes local pH values to fall below the 
critical value resulting in diffusion of calcium, phosphate and carbonate out of the tooth 
causing demineralisation (Dawes, 2003, Featherstone, 2008). If pH continues to drop, 
the balance between demineralisation and remineralisation of tooth tissue tips towards 
demineralisation and if allowed to continue, cavitation that is clinically obvious will 
eventually occur (Featherstone, 2008). 
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1.1.2 Demineralisation and remineralisation 
Under physiological conditions, the saliva in the oral cavity is supersaturated with 
hydroxyapatite and fluoroapatite, and therefore the enamel surface is in a state of 
dynamic equilibrium with its surrounding environment. The solubility of the enamel 
apatite on the tooth surface is directly related with the pH of the surrounding medium 
(saliva). Therefore a drop in salivary pH would result in an increase of apatite solubility 
(Kidd, 2016). In general, the solubility of apatite increases 10 times with a decrease of 
1.0 pH unit. For hydroxyapatite, the critical pH is around 5.5, while it is approximately 4.5 
for fluoroapatite (Buzalaf et al., 2011) 
At the critical pH, equilibrium exists (no mineral loss or gain). When the pH is over the 
critical level, mineral precipitation occurs (Remineralisation). On the other hand, when 
pH is below the critical value, mineral dissolution occurs (Demineralisation) (Buzalaf et 
al., 2011). 
The dynamic process of demineralisation and remineralisation occurs on multiple 
occasions throughout the day, but as long as there is no net irreversible loss of minerals, 
the damage to the tooth is reversible (Fejerskov and Kidd, 2008) . 
For this reason demineralisation can be defined as “The chemical loss of calcified 
material from the structure of the tooth, which can be biofilm mediated (caries) or 
chemically mediated (erosion) from exogenous or endogenous sources of acid (diet, 
environment, or stomach)” (Longbottom et al., 2009). 
On the other hand remineralisation can be defined as “The net gain of calcified material 
within the tooth structure, replacing that which was previously lost through 
demineralization” (Longbottom et al., 2009). 
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1.1.3 Enamel caries (white spot lesion) formation 
Enamel is a translucent tissue and is the hardest calcified matrix in the body. Fully 
formed enamel consists of approximately 96% mineral and 4% organic material and 
water, and the inorganic content of enamel is a crystalline calcium phosphate 
(hydroxyapatite) (Nanci and Ten Cate, 2013). 
Kidd (2016), explains how incipient enamel lesions develop and progress. Dental carious 
lesions are a result of an imbalance in physiological equilibrium between tooth mineral 
and biofilm fluid, and they present as a consequence of biofilm activity. As the pH is 
lowered in the oral fluids below the critical pH of hydroxyapatite, the hydroxyapatite in 
saliva is dissolved and drops from supersaturated to saturated. Fluorapatite has a lower 
critical pH than hydroxyapatite and therefore maintains its integrity, and the plaque saliva 
maintains fluorapatite at a supersaturated level. When the hydroxyapatite level drops, 
demineralisation of enamel occurs and a sub-surface enamel carious lesion begins to 
forms, while fluorapatite continues to be deposited at the surface of the lesion forming an 
intact surface zone. This surface zone exerts a protective effect, to prevent further 
dissolution of the of lesion body as long as the pH fluctuations are above the critical pH 
of fluorapatite. 
If the pH drop is constant or maintained for a prolonged period, the dissolution of mineral 
continues along the naturally occurring enamel rods in a cone shape, with the base of 
the cone at the enamel surface and the apex pointing toward the dentin-enamel junction, 
and eventually cavitation will occur (Kidd, 2016). 
Enamel caries can be described histopathologically in ground sections as having four 
distinct zones. The optical properties of each zone reflect different degrees of 
demineralisation (Gustafon, 1957, Kidd and Fejerskov, 2004, Soames and Southam, 
2005): 
 
 
4 
 
1. The translucent zone: found at the advancing edge of the lesion, is more porous 
than normal enamel (1% volume of spaces compared to 0.1% pore volume 
respectively). Dissolution of minerals occurs mainly at the junctional areas 
between the prismatic and inter-prismatic enamel. 
2. The dark zone: contains 2-4% by volume of pores , some pores are large but 
others are smaller than the translucent zone indicating that some mineralisation 
has occurred due to re-precipitation of mineral lost from the translucent zone, 
this leads to the theory that in rapidly advancing lesions the dark zone is 
narrower as less remineralisation is occurring (Shellis et al., 2002). 
3. The Body of the lesion: has a pore volume of between 5 and 25% and contains 
apatite crystals larger than those found in normal enamel, suggesting re-
precipitation of mineral dissolved from deeper zones. However with continuing 
pH challenge mineral continues to dissolute from both the periphery and the 
core. There is an increase in prominence of striae of Retzius in this zone. The 
explanation for this is unknown. 
4. The Surface zone: is approximately 40 µm thick with minimal changes in early 
lesions. This is because of mineral re-precipitation from both the plaque and 
from the dissolved deeper zones of the lesion as ions diffuse outwards. 
The incipient enamel lesion develops initially as a subsurface translucent zone, which 
then enlarges and develops a dark zone at it centre. As more mineral is lost, the lesion 
enlarges and the centre of the dark zone becomes the body of the lesion. At this stage 
the lesion will be clinically recognisable and will present as a white spot (Murray et al., 
2003). 
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1.1.4 The role of saliva 
Saliva is a mixed fluid in the oral cavity in contact with the teeth and oral mucosa. Saliva 
is composed of more than 99% water, and less than 1% solids (mostly electrolytes and 
proteins), and is produced by the salivary glands at a rate of 0.5-1.0 Litres per day 
(Humphrey and Williamson, 2001, Fejerskov and Kidd, 2008) 
Saliva has a major role in protection against dental caries. It protects the dentition by 
clearing it from bacteria and debris, saliva also has a buffering action due its bicarbonate 
and phosphate ion constituents which help raise the pH after an acidic challenge. Some 
basic salivary proteins may also contribute to the buffering action of saliva. Saliva also 
maintains tooth integrity because of its supersaturation with calcium and phosphate and 
fluoride ions, which when present at the tooth surface increase surface hardness and 
resistance to demineralisation, and facilitate remineralisation of incipient lesions. Last but 
not least, saliva has antimicrobial properties due to the presence of immunoglobulin A 
(IgA) and lysosomes, which help decrease bacterial colonisation of oral tissues 
(Humphrey and Williamson, 2001, Dodds et al., 2005). 
1.2 Fluoride’s role in caries prevention and remineralisation 
Dental caries is the most prevalent chronic disease, afﬂicting a signiﬁcant proportion of 
the world population, including around 60% to 90% of school-aged children and the vast 
majority of adults (Marcenes et al., 2013).  
Over 70 years ago, fluoride was introduced into dentistry, and it is now recognised as the 
main factor responsible for the dramatic decline in caries prevalence that has been 
observed worldwide (Featherstone, 1999, Petersen and Ogawa, 2016). 
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1.2.1 The Fluoride ion 
The Fluoride ion is an inorganic anion of fluorine with the chemical formula F−. Fluoride 
is the simplest anion of fluorine. Its salts and minerals are important chemical reagents 
and industrial chemicals, mainly used in the production of hydrogen fluoride for 
fluorocarbons. In terms of charge and size, the fluoride ion resembles the hydroxide ion. 
Fluoride is odourless and tasteless (Wells, 2008).   
Fluoride occurs naturally in soil, water, foods, and several minerals, such as fluorapatite 
and fluorite. Fluoride concentration in seawater averages 1.3 ppm. In the ground water 
the concentration of fluoride depends on the nature of the rocks and the occurrence of 
fluoride-bearing minerals. Natural fluoride is seen in high concentrations in well water 
because fluoride is dissolved from rocks to groundwater (Fawell et al., 2006). Fluorides 
reach their highest concentration in siliceous rocks, alkaline rocks, geothermal waters, 
hot springs and volcanic gases (Axelsson, 2004) 
It has been estimated that around 60-80% of human intake of fluoride occurs from 
drinking water and beverages, 6-8% from cereal products and grains, 5-7% from meat, 
fish and poultry, and 10-14% from all other foods (Axelsson, 2004). 
1.2.2 Mechanism of action of fluoride 
It has been suggested that fluoride has several caries protective modes of action, 
including both topical and systemic effects. During tooth development fluoride has a 
systemic effect that is exerted onto developing enamel that leads to replacement of 
hydroxyapatite crystals with the more stable and acid resistant fluorapatite crystals 
(Robinson, 2009). Furthermore fluoride has been found to have an effect on tooth 
morphology, as teeth that are formed in fluoridated environments tend to be smaller and 
have shallower pits and fissures than those formed in non-fluoridated environment. The 
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advantage of this is decreased plaque retention in the shallower pits and fissures. 
Unfortunately the evidence for this is poor (Lovius and Goose, 1969, Featherstone, 
1999). 
Research has shown that even though fluoride has a systemic action, its topical action is 
significantly more important. Inhibition of demineralisation and promotion of 
remineralisation of enamel are crucial to the caries protection process. When the pH of 
oral and plaque fluids drop below the critical pH of hydroxyapatite, Fluoride promotes 
remineralisation of demineralised enamel by substituting hydroxyapatite crystals with 
fluorapatite. Fluorapatite crystals are larger than hydroxyapatites, more stable and more 
resistant to acid dissolution as they have a lower critical pH (ten Cate, 1999, Buzalaf et 
al., 2011). 
Although the main action of fluoride is on the prevention of demineralisation and the 
promotion of remineralisation of hard dental tissues, it has also been proposed that the 
fluoride ion can affect the physiology of the microbial cell. Fluoride exerts it effects on 
bacteria by direct inhibition of cellular enzymes, or by enhancing proton permeability of 
cell membranes in the form of hydrogen fluoride HF (ten Cate, 1999, Marquis et al., 
2003, Koo, 2008, Fernandez et al., 2016). 
1.2.3 Fluoride toxicity  
As is true of virtually all substances to which humans are exposed, including water, 
oxygen and table salt, exposure to high amounts of fluoride can cause adverse effects. 
Fluoride toxicity can be either acute which is associated with ingestion of a large amount 
of fluoride over a short period of time, or it can be chronic which is associated with 
ingestion of smaller amounts of fluoride but over a prolonged period of time. In either 
case the signs and symptoms are dose dependant (Whitford, 2011). 
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1.2.3.1 Acute Fluoride Toxicity 
Historically, there have been many cases and reports of accidental fluoride poisoning. 
From those reports, researchers have been able to determine the signs and symptoms 
of acute fluoride toxicity, and  estimate the doses of fluoride ingestion that may cause 
serious toxicity (Lidbeck et al., 1943, Hodge and Smith, 1965, Eichler et al., 1982, McIvor 
et al., 1983). 
Following ingestion of al large amount of fluoride, the first organ to be affected is the 
stomach. Symptoms of acute fluoride toxicity are nausea, bloody or normal vomiting, 
diarrhoea and fatigue. This will be followed by general collapse accompanied by pallor, 
weakness, shallow breathing, weak heart sounds, wet cold skin, cyanosis and equally 
dilated pupils. Death may occur within 2-4 hours, but if delayed for up to 20 hours, 
muscle paralysis, carpopedal spasm and spasms of extremities occur. This is associated 
with electrolyte imbalance, particularly severe hypocalcaemia and hyperkalaemia 
(Whitford, 2011). 
Based on the reports of the mass poisoning of the Oregon state hospital, where about 10 
gallons of scrambled eggs were mistakenly prepared with 17 pounds of sodium fluoride 
instead of powdered milk, causing 263 cases of acute poisoning of which 47 were fatal 
(Lidbeck et al., 1943), Hodge and Smith (1965) estimated that the certainly lethal dose 
was between 32 and 64 mg/kg sodium fluoride. 
The potentially toxic dose, which is “The minimum dose that could cause serious life 
threatening systemic signs and symptoms and that should trigger immediate therapeutic 
intervention and hospitalisation”, was estimated to be 5.0 mg/kg (Dukes, 1977). 
The immediate treatment of acute fluoride toxicity should be aimed at reducing the 
amount of fluoride available for absorption from the gastrointestinal tract. Vomiting 
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should be induced if the patient is conscious, and has a gag reflex. If the patient is 
unconscious avoid induction of vomiting to prevent aspiration into the lungs. Because of 
the strong affinity of calcium for fluoride absorption can be slowed by oral administration 
of 1% calcium chloride or calcium gluconate or, if these solutions are unavailable, as 
much milk as the patient can tolerate. The hospital emergency department should be 
informed, and the patient transported as soon as possible. A gastric lavage may be 
performed with a solution containing calcium or activated charcoal, and blood samples 
should be obtained to check for hypocalcaemia and hyperkalaemia (Whitford, 2011)  
1.2.3.2 Chronic Fluoride Toxicity 
Excess ingestion of fluoride over a prolonged period of time, can cause dental fluorosis, 
skeletal fluorosis and kidney damage. Fluoride is incorporated into the forming apatite 
crystals of both bone and teeth as they act as a reservoir for fluoride. The severity of 
dental fluorosis is related to the concentration of fluoride in the plasma, the stage of 
crown formation, and the duration of exposure to fluoride (Dean et al., 1950, Denbesten 
and Li, 2011). 
1.2.4 Oral Fluoride Reservoirs 
Teeth, saliva, oral mucosa and dental plaque fluids all act as reservoirs for the fluoride 
ion in the oral cavity. Of those previously mentioned, plaque fluids and saliva are the 
most important fluoride reservoirs due to their close association with the tooth surface.  
Oral fluoride reservoirs can be broadly classified into two broad types, both of which 
involve calcium (Ca) (Vogel, 2011): 
1. The mineral deposits of fluoride, which include calcium fluoride (CaF2) and 
fluorapatite (FAp) 
2. The biologically or bacterially bound calcium fluoride deposits (Ca-F) 
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The importance of maintaining a caroiostatic concentration of fluoride in the oral fluids 
has been emphasized in current research to facilitate anti caries effects of fluoride. 
Fluoride present in solution at low levels amongst the enamel crystals can markedly 
inhibit dissolution of tooth mineral by acid (Featherstone, 1999). Salivary fluoride levels 
as low as 0.01-0.10 ppm have been shown to be effective in the prevention of the 
enamel dissolution (Hellwig and Lennon, 2004). 
Multiple systematic reviews and studies have shown that the principle action of fluoride is 
through its topical rather than its systemic effect (Marinho et al., 2003, Twetman et al., 
2003, Twetman, 2009). Steady presence  of fluoride at low levels (sub-ppm) in the 
plaque enamel interface during acid insult will inhibit demineralisation, and when PH is 
restored traces of fluoride in solution will speed up the remineralisation process (Buzalaf 
et al., 2011). This indicates that the frequency of application and constant availability of 
fluoride is more crucial than the quantity of fluoride administered. 
1.3 Toothpastes 
Over the years, toothpaste has evolved, developed, taken many forms and contained 
multiple constituents. It started out as tooth powder containing crushed egg shells and 
ashes invented by the ancient Egyptians (3000-5000 BC), and continued to be modified 
by different cultures and civilisations until it reached its modern structure and 
appearance (Lippert, 2013). 
Nowadays toothpastes are a mixture of abrasive suspended in an aqueous humectant 
phase by means of a hydrocolloid. In this matrix, surfactants, active (therapeutic) 
ingredients, preservatives colourings, sweeteners, flavour compounds and other 
ingredients are embedded (Lippert, 2013). Toothpastes have become accepted 
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worldwide as the dominant vehicle of topical fluoride delivery, for caries preventative 
means (Zero, 2006, Walsh et al., 2010). 
1.3.1 Toothpaste excipients (Vranic et al., 2004, Davies et al., 2010, 
Yavnai, 2010, Lippert, 2013): 
1.3.1.1 Abrasives: 
Abrasives are substances that clean and polish the tooth surfaces. The most commonly 
used abrasives are calcium carbonate, alumina and dicalcium phosphate. Calcium 
phosphate and alumina are cheap ingredients but cannot be used with sodium fluoride 
as they will have unfavourable reaction with the free fluoride ions forming calcium 
fluoride. However, dicalcium phosphate can be formulated with either sodium phosphate 
or sodium monofluorophosphate. 
Nowadays, most toothpastes contain silica, which is more expensive but can be 
combined with many fluoride salts. Its use has enabled adding sparkles and colouring 
agents to toothpastes. The concentration of silica varies between 10-20%. 
1.3.1.2 Surfactants: 
Surfactants are not only responsible for the foaming action of toothpastes, but they also 
aid in their intraoral dispersion. The most widely used agent is sodium lauryl sulphate, 
which is usually included at a concentration between 0.5 - 2.0%. 
1.3.1.3 Viscosity and rheology modifiers: 
Their primary function is to produce a gel phase containing a homogenous distribution of 
all ingredients, and to prevent components from separating during long periods of 
storage. Furthermore they are responsible for easy flow and clear break rather than 
stringy appearance when applied to a toothbrush. The most common are 
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carboxymethylcellulose, xanathan gum and cellulose gum at conc. ranging from 0.5-
2.0%. 
1.3.1.4 Humectants: 
Used to avoid water separation and evaporation (drying of toothpaste), and to provide 
smooth glossy appearance. Glycerine and sorbitol are most commonly used due to their 
compatibility with other materials and their raw material cost. 
1.3.1.5 Flavours and sweeteners: 
Added primarily for palatable reasons, they mask the often unpleasant taste of 
surfactants, provide breath freshening and sensorial cues such as cooling, heating or 
tingling. Flavours are the most expensive and most volatile excipient and can be used at 
concentrations below 0.5%. All commonly used sweeteners are artificial, and the majority 
of toothpaste manufactures utilize either sodium saccharine or sucralose. Xylitol can also 
be considered a sweetener, although its main and still discussed purpose is caries 
prevention. 
1.3.1.6 Fluoride (Active ingredient): 
Of the many active ingredients found in different toothpastes Fluoride is by far the most 
important in caries prevention and enamel remineralisation. According to the EAPD 
policy document on the use of fluoride in children ‘’ The extensive use of fluoridated tooth 
pastes has probably been one of the major reasons for the dramatic reduction in dental 
caries recorded over the past 30 years.’’ (European Academy of Paediatric Dentistry, 
2009). 
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1.3.2 Fluoride reservoirs in toothpastes 
In toothpastes there are distinct fluoride reservoirs: ionic fluoride which is readily 
available in aqueous solutions; ionisable fluorides like MFP which will release ionic 
fluoride in the mouth upon action of oral phosphates; and insoluble fluoride formed by 
undesirable reaction of fluoride with calcium based abrasives, such as dicalcium 
phosphate dehydrate (CaH2PO4.2H2O) and calcium carbonate (CaCO3) (Tenuta and 
Cury, 2013). To avoid these unwanted reactions, silica can be used as an abrasive 
material instead of the calcium based abrasives, although this will render the product 
more expensive to manufacture. Another way to elude the reaction of fluoride with 
calcium is by using sodium MFP/CaCO3 however it may hydrolyse with time, perhaps 
resulting in a less soluble fluoride (Tenuta and Cury, 2013). 
A key factor in the cariostatic efficiency of fluoride toothpaste is the ability to form 
calcium fluoride-like globules when contacting the enamel or dentine surface (ten Cate, 
1997, Featherstone, 1999). This desirable reaction is not to be confused with the 
undesirable reaction of fluoride with calcium based abrasives in the tube. During the time 
between fluoride exposures fluoride is slowly released from the compound into the oral 
fluids, maintaining a steady level of fluoride protection (Petzold, 2001). Petzold 
demonstrated the different calcium fluoride deposition rates between multiple fluoride 
formulations, (AmF, NaF, and MFP) showing that AmF had the highest and fasted 
accumulation rate, followed by NaF, then NaMFP. The result of this study was in 
agreement with previous investigations on, calcium fluoride deposition (Cruz et al., 1992) 
1.3.3 Different Fluoride Formulations in toothpaste 
Fluoride bioavailability in the oral fluids in the form of the F- ion is essential for it to be 
effective in the demineralisation and remineralisation process. It can be delivered from 
toothpastes in different fluoride formulations. Different fluoride formulations differ in their 
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chemical structures, which in turn has implications on the mode of action for each 
formulation. According to Axelsson (2004) the three main categories are: 
1. Inorganic compounds: including sodium fluoride (NaF) and stannous fluoride 
(SnF). These are readily soluble salts that provide free fluoride 
2. Monofluorophosphate containing compounds: such as sodium 
monofluorophosphate (MFP). The Fluoride is covalently bound to phosphate 
ions, and requires hydrolysis to release the fluoride ions 
3. Organic fluorides: such as amine fluoride (AmF). Fluoride is  bound to organic 
compounds 
Sodium fluoride (NaF): 
Sodium fluoride is an inorganic compound, and is by far the most commonly used 
fluoride formulation in topical fluoride agents both for self-application and professional 
use. When in solution, NaF salt readily releases fluoride into saliva, dental plaque, 
pellicle and enamel crystallites. NaF is widely used in many fluoride vehicles including 
dentifrices, mouth rinses, chewing gums, solutions, gels, varnishes, prophylaxis pastes 
and slow release devices (Axelsson, 2004, Fejerskov and Kidd, 2008, Pessan et al., 
2011). 
Stannous fluoride (SnF): 
SnF is an inorganic compound that releases both F-  which have both cariostatic and 
antibacterial properties, and Sn+2 ions which have antimicrobial properties into the oral 
environment. Tooth staining and instability are the main disadvantages of this 
formulation. SnF is used in dentifrices, mouth rinses, solutions, gels, and  prophylaxis 
pastes (Axelsson, 2004, Fejerskov and Kidd, 2008, Pessan et al., 2011). 
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Sodium monofluorophosphate (Na2FPO3)(NaMFP): 
NaMFP is a monofluorophosphate containing compound, that can be used in both 
neutral and acidic vehicles. Fluoride is covalently bound in Na2FPO3 and requires 
hydrolysis in order to release fluoride ions. The NaMFP containing products provide 
FPO3 (MFP) ions together with some free F- ions, both which can diffuse through the 
plaque and into enamel. This provides a source of the free F- ion prior to hydrolysis. 
FPO3 can be hydrolysed in plaque. Under acidic conditions, FPO3 can also be 
hydrolysed at the surface of apatite crystals, providing phosphate and fluoride ions 
(Axelsson, 2004).One of the main advantages of NaMFP is its compatibility with calcium 
based abrasives as FPO3 requires hydrolysis prior to release of free F- therefore avoiding 
the production of insoluble fluoride formed by undesirable reaction of fluoride with 
calcium based abrasives, such as dicalcium phosphate dehydrate (CaH2PO4.2H2O) and 
calcium carbonate (CaCO3) (Tenuta and Cury, 2013). NaMFP can is used in dentifrices 
(at neutral pH) and gels (both acidic and neutral pH) (Axelsson, 2004, Fejerskov and 
Kidd, 2008, Pessan et al., 2011). 
Amine fluoride (AmF): 
AmF is an organic fluoride compound, that readily provides free fluoride. Its enhanced 
caries protective action has been attributed to the greater affinity of hydrophilic counter-
ions to the enamel, which will reduce the surface energy and thereby the plaque 
adhesiveness of enamel . In addition, AmF provides a complexed store of fluoride ions 
and may enhance diffusion through carious enamel (Axelsson, 2004, Fejerskov and 
Kidd, 2008, Pessan et al., 2011)  
 
In light of the multiple available fluoride formulations, a question comes to mind. What 
optimum fluoride formulation gives the highest extent of remineralisation of a 
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demineralised enamel lesion? The answer has been a matter of heated debate over the 
years. There have been a vast number of studies comparing the anti-caries effects 
between different fluoride compounds in dentifrices with the majority of them comparing 
only between two compounds, and only a handful comparing all the main fluoride 
compounds in dentifrices (Toda and Featherstone, 2008). 
1.3.3.1 Studies reporting no difference between fluoride formulations 
A Cochrane review by Marinho et al. (2003) to determine the effectiveness and safety of 
ﬂuoride toothpastes in the prevention of caries in children, compared toothpastes 
containing MFP (22 trials), SnF (19 trials), NaF (10 trials) and AmF (5 trials) and did not 
find an link between the type of fluoride compound in the dentifrice and the magnitude of 
treatment effect. In spite of their findings the authors considered their results to be less 
reliable than evidence from head to head comparisons (Pessan et al., 2011). 
A meta-analysis of clinical studies comparing the anti-caries protection of NaF against 
NaMFP had come to the same conclusion a few years before it (Proskin, 1993), these 
results are harmonious with other pieces of literature: (DePaola et al., 1993, Volpe et al., 
1995, Saporito et al., 2000). 
Furthermore some animal and in vitro studies have also concluded that both NaF and 
AmF have the same caries reducing (prevent demineralisation and promote 
remineralisation) abilities (Warrick et al., 1999, Holler et al., 2002, Toda and 
Featherstone, 2008). 
1.3.3.2 Studies reporting NaF Superiority 
Stookey et al. (1993) published a meta-analysis of clinical studies that gave inconsistent 
results with the studies mentioned previously. Results of the analysis demonstrated that 
NaF was significantly more effective than MFP in preventing caries by 5-20%. Based 
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upon their clinical findings the authors recommend that NaF be used as the active 
system in fluoridated dentifrices whenever practically feasible. 
An in vitro pH cycling model demonstrated that NaF was statistically better at enamel 
remineralisation than MFP when lesions were assessed by cross sectional micro 
hardness (Toda and Featherstone, 2008). As with most reports claiming the superiority 
of NaF against MFP, their claims were built on the assumption that fluoride only exerts 
its effects on demineralisation and remineralisation as a free ion. Unlike NaF (which 
releases free F-),  fluoride in MFP formulation is covalently bound to phosphate and 
requires enzymatic hydrolysis to release free F- (Pessan et al., 2011). 
In a recent in vitro study evaluating remineralisation of carious lesions and fluoride 
uptake by enamel exposed to various fluoride dentifrices, it was found that enamel 
remineralisation and fluoride uptake was significantly greater when using NaF compared 
to MFP. It was also concluded that efficacy of the fluoride dentifrice was dependant on 
ionic fluoride levels (Hattab, 2013). 
1.3.3.3 Studies reporting AmF superiority 
Adding to the controversy, more inconsistent results have been published elsewhere in 
the literature. A recent in vitro study by Patil and Anegundi (2014), evaluated the 
remineralisation, and fluoride uptake by tooth enamel from four different fluoride 
dentifrices (Naf, MFP, SnF, and AmF). Results from the study indicated that enamel 
treated with amine fluoride had the highest fluoride uptake. These results were 
consistent with other in vitro studies (Arnold et al., 2006, Chan et al., 1991, Klimek, 1998, 
Cate, 2008, Altenburger et al., 2010), in situ studies (Buchalla et al., 2002), clinical 
studies (Cahen et al., 1982) and a review of Hungarian studies on AmF (Madlena, 2013). 
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In Madlena’s review, it was concluded that the use of products containing, AmF and 
SnF2 resulted in beneficial clinical effects on development of carious lesions. Amine 
fluoride is an organic fluoride unlike the other inorganic fluoride compounds used in the 
previous studies. The reason behind AmF’s high uptake into enamel is the result of high 
distribution of organic material in enamel after its demineralisation, and that the cations 
in AmF have a hydrophilic and hydrophobic part (as in other surfactants). The 
hydrophobic part is aligned towards the oral cavity away from the tooth surface and the 
hydrophilic part, containing the fluoride ions towards the enamel or dentin surface. This 
causes the fluoride ions to accumulate close to the tooth surface facilitating the 
production of calcium fluoride as a labile reservoir or for immediate remineralisation. The 
surface layer of calcium fluoride is stabilised by the hydrophobic part of the molecule 
pointing towards the oral cavity, which reduces moistening by saliva and prevents it 
being washed out rapidly. Other fluoride compounds mentioned previously are inorganic 
fluorides which are lost by way of ionic exchange in saliva (Patil and Anegundi, 2014, 
Madlena, 2013). 
The pH of AmF containing dentifrices also has a direct effect on its ability to remineralise 
enamel. Slightly acidified AmF containing dentifrices may have a positive effect on 
enamel remineralisation (Arnold et al., 2007). This phenomenon may be explained by the 
inverse relationship between calcium fluoride and pH, and also by increased plaque 
fluoride uptake in low pH environment when compared to neutral formulations (Pessan et 
al., 2011). 
1.3.4 Different Fluoride Concentrations 
The association between the concentration of fluoride in toothpaste and its clinical 
effectiveness has long been debated in the literature. Multiple studies have compared 
 
 
19 
 
high concentration fluoride versus low concentration fluoride toothpastes (Walsh et al., 
2010) . 
A randomised controlled trial conducted by Davies et al. (2002) assessed the impact of 
providing free fluoride toothpaste containing either 450ppm fluoride or 1450ppm fluoride 
on the level of caries in the deciduous dentition. The toothpaste was provided at 3 
monthly intervals from the age of 12 months until 5-6 years. The results indicated a 
statistically significant difference of the dmft (16% reduction) between the 1450ppm and 
the control group. Though, the difference between the 440ppm and the control group 
was not statistically significant. 
Biesbrock et al. (2003a) conducted a randomised double-blind study to assess the anti-
caries effectiveness of placebo, 500ppm fluoride and 1450ppm fluoride dentifrices. The 
657 subjects were randomly assigned to the 3 different groups for the first 9 months of 
the study. Subjects of the placebo group were then assigned to the 500ppm or 1450ppm 
fluoride groups for the rest of the study time, whilst all other subjects continued with their 
original treatment assignments.  
The results of the study differed from those of Davies et al. (2002) in that both 500ppm 
and 1450ppm fluoride toothpastes delivered statistically significant lower dmft scores 
than the placebo toothpaste at 9 months and the same significant result was found for 
the 500ppm and the 1450ppm fluoride dentifrice when compared to placebo/500ppm and 
placebo/1450ppm fluoride at 21 months. 
In October of the same year Biesbrock et al. (2003b) published another randomised 
double-blind study to assess anti-caries effectiveness of placebo, 1100 ppm sodium 
fluoride and 2800 ppm sodium fluoride dentifrices. The 644 subjects were randomly 
assigned into three groups as in the previous trial. Results were consistent with the 
previous study, as both 1100 and 2800 ppm fluoride showed a statistically significant 
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lower  DMFS score when compared with placebo. Furthermore 2800 ppm group 
presented with a statistically significant lower DMFS score at 21 months indicating a 
dose response to fluoride. 
Twetman et al. (2003) carried out a systematic review of the literature between the years 
1966-2003 and found limited evidence for an anti-caries difference between low-fluoride 
(<1000ppm) and standard fluoride (1000-1100ppm) toothpastes in the young permanent 
dentition. Strong evidence was reported for the superior preventive effect of toothpastes 
with 1500ppm of fluoride compared with standard ones with 1000ppm fluoride when 
used daily during the young permanent dentition. An update of the systematic review 
(Twetman, 2009), produced results that reinforced the original findings. 
A meta-analysis by Steiner et al. (2004) comparing the effect of 1000 ppm to the effect of 
250 ppm fluoride toothpaste found a 13-14% reduction in caries increments for the group 
using 1000 ppm fluoride toothpaste. These results were in line with the systematic 
reviews published by (Twetman et al., 2003, Twetman, 2009). 
A randomised controlled trial by Lima et al. (2008), evaluated the effect of low-fluoride 
dentifrice on children with different caries experience. One hundred and twenty 2 to 4 
year old children, half with and half without active caries lesions were randomly divided 
into two groups which used either 500ppm or 1100ppm dentifrices. The results pointed 
out that the anti-caries effect of the 500ppm dentifrice was similar to the 1100ppm when 
used by caries inactive children. Though, 1100ppm toothpaste was more effective than 
500ppm for caries active young patients. One of the major shortcomings of this clinical 
trial was that there was insufficient follow up time (one year) allowed to assess caries 
progression or arrestment.   
A Cochrane review by Walsh et al. (2010) that included 75 studies, indicates that the 
caries preventive effect of fluoride toothpaste increases significantly with higher fluoride 
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concentrations. When compared to placebo. Concentrations of 440,500,550ppm fluoride 
and below show no statistically significant effect, but a statistically significant effect is 
evident for 1000,1055,1100,1250ppm fluoride concentrations (prevented fraction: 25%) 
and for highest fluoride concentrations (prevented fraction: 45%). For the active 
interventions, only the prevented fraction for comparisons of 250ppm with 
2400,2500,2800ppm and 1000,1055,1100,1250ppm with 2400,2500,2800ppm attain 
statistical significance. The authors concluded that only fluoride toothpaste at a 
concentration of 1000 ppm fluoride and above is efficient at preventing dental caries. 
1.4 Model systems used in coronal caries research 
A well conducted randomised controlled clinical trial is considered the gold standard 
model used to study the caries process and progression in enamel (Scottish 
Intercollegiate Guideline Network, 2017). However conducting a randomised controlled 
trial is both costly and requires a prolonged period of time. Therefore different models 
that can mimic the oral environment have been developed and adopted. 
1.4.1 In vitro model 
Prior knowledge of the in vivo situation is required in order to set up an in vitro model. In 
vitro caries models in general have been adopted due to their ability to help us 
understand the complex process of caries development and prevention. They help us 
accurately predict a clinical outcome in a controlled and simplified way. Even though a 
model cannot capture all the details involved with caries formation, it can give us a 
means of performing reproducible experiments under controlled conditions (Buzalaf et 
al., 2010). 
In vitro or laboratory models are the most commonly used systems in caries research. 
They have several advantages including (Xuedong, 2016): 
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1. Lower cost, and can be produced more rapidly. 
2. The possibility of carrying out single variable experiments under highly controlled 
conditions, which are more sensitive and precise. 
3. Best approach to screen a large number of agents to determine their modes of 
action. 
4. The ability to bypass ethical issues that are associated with in vivo models (Salli 
and Ouwehand, 2015). 
However in vitro models also have limitations which include: 
1. Inability to simulate the complex biological processes associated with caries 
(Xuedong, 2016). 
2. Inability to replicate and reproduce precisely the conditions of the oral 
environment (Higham et al., 2005). 
1.4.1.1 pH cycling model 
In vitro pH cycling models mimic the dynamics of mineral loss or gain involved in the 
caries process, and the have been used widely to evaluate the efficacy of fluoridated 
toothpastes on caries control (Buzalaf et al., 2010). The origin of the modern pH cycling 
models was produced by ten Cate and Duijsters (1982). 
Stookey et al. (2011) published a study that looked at the robustness, and the ability to 
predict the anti-caries performance of fluoride containing products by using the in vitro 
pH cycling model. He compared data from three independent laboratories and concluded 
that the in vitro pH cycling model: 
1. Was capable of measuring the dose response from 0-1100 ppm F. 
2. The model was able to statistically separate positive from negative control. 
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3. Dentifrice formulations proven to be clinically effective against caries, performed 
in this model at a level that was not statistically less effective than the positive 
control. 
4. This model was able to statistically differentiate between a product with 
attenuated fluoride activity (product formulated with the same level of fluoride as 
the positive control in addition to an ingredient known to compromise fluoride 
effectiveness) from the positive control. 
For the reasons mentioned above, in vitro pH cycling continues to be an effective tool in 
evaluating the efficacy of fluoridated toothpastes on caries control. 
1.4.1.2 Dental substrates that can be used in the pH cycling model 
Human teeth can be regarded as the most appropriate source of dental substrate to be 
used in pH cycling models in terms of clinical relevance. However, their composition is 
variable, due to genetic influences, environmental conditions and age. These differences 
lead to large variations in their response under acidic challenges (Buzalaf et al., 2010). 
Furthermore, sources of human teeth are becoming more and more limited and there is 
a significant increase in difficulty of obtaining human teeth for research purposes 
(Stookey et al., 2011). 
Bovine teeth are easier to obtain, have a more uniform composition when compared to 
human teeth, and have been generally demonstrated to perform similarly to human teeth 
(Tanaka et al., 2008, Costa et al., 2015). For this reason, bovine enamel can offer a 
suitable alternative to human enamel for in vitro pH cycling models, and they provide a 
less variable response to both cariogenic challenge and anti-caries treatment such as 
fluoridated dentifrices (Mellberg, 1992, ten Cate and Mundorff-Shrestha, 1995). 
However, due to slight differences between bovine and human enamel in terms of 
mineral content and porosity (Edmunds et al., 1988), Stookey et al. (2011) has found that 
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slight adjustment and increase of demineralisation pH was necessary to achieve similar 
results. Although bovine enamel is more porous than human enamel, which leads to 
faster demineralisation and remineralisation, these differences result in quantitative and 
not qualitative differences in behavior (Buzalaf et al., 2010). 
Artificial caries lesions produced from bovine teeth, have a mineral distribution and 
structure that resembles lesions produced from human teeth for both enamel and dentin 
(Featherstone and Mellberg, 1981, Mellberg, 1992).  
1.4.1.3 Characteristics of the artificial caries lesion used in the pH cycling 
model 
Different models for pH cycling have unique protocols for producing artificial caries 
lesions. Methods include immersion enamel substrates in buffered lactate or acetate 
gels, or the use of solutions under saturated in respect to apatite, with a pH ranging 
between 4.4 and 5.0, for a time ranging between 16 h and 28 days (Buzalaf et al., 2010). 
Lesions formed will depend on the protocol used and they include surface softened 
erosion like lesions or, subsurface caries like lesions. For caries research, subsurface 
enamel lesions are required to demonstrate the remineralisation potential of different 
treatments on the demineralised enamel (Buzalaf et al., 2010). 
1.4.2 Animal caries models 
Animal caries models are invaluable tools to simulate the natural progression of caries 
under biological conditions, and they have a long history of successful use in caries 
research. Controlled conditions can be created with the use of this model by 
manipulating oral microflora, and providing a specific diet. Furthermore, unlike in vitro or 
in situ models, which measure isolated components of the caries process, animal caries 
models truly measure caries (Stookey et al., 1995). 
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There are many similarities between carious lesions developed in rat models, and caries 
developed in human models which include;  cariogenic microorganisms, the presence of 
fermentable carbohydrates in the diet, the demineralization pattern of the enamel, and 
the responsiveness to fluoride. However, the morphology of the teeth and the eating 
habits differ. Furthermore, the oral and plaque microflora are dissimilar and therefore this 
model has faced protest over the years (Stookey et al., 1995). 
1.4.3 In situ model 
In situ caries models involve the use of appliances or devices in the human mouth to 
simulate the natural process of dental caries. These models attempt to provide clinically 
relevant information in a relatively short period without causing irreversible tissue 
changes in the natural dentition. The advantages of in situ caries model systems 
compared with clinical trials include (Higham et al., 2005): 
1. Fewer ethical and logistical problems. 
2. Lower cost and results are obtained in a shorter time. 
3. The experimental design can be more flexible, allowing the hypothesis to be 
tested. 
4. The data is highly reproducible and recoverable from archives. 
When comparing this model with the in vitro model, In situ caries model are also 
influenced  by dietary eating habits, the presence of human saliva, plaque of varying 
composition and thickness, and a pellicle-coated tooth surface. All these factors make 
the test conditions more similar to the oral environment . However, The validation of 
these studies rely heavily on the compliance of the test subjects (Zero, 1995). 
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1.5 Methods used in Demineralisation and Remineralisation 
Evaluation 
Multiple  techniques are available for measuring mineral loss or gain during enamel 
demineralisation and remineralisation. Techniques available can either be destructive or 
non-destructive to enamel. 
1.5.1 Quantitative Light-Induced Fluorescence (QLF) 
The phenomenon of tooth fluorescence has long since been suggested as a useful tool 
for the detection of dental caries (Benedict, 1929). 
Quantitative light induced fluorescence (QLF) is based on the principle that excitation of 
dentin with blue light (370 nm) causes it to fluoresce in the yellow-green region. By using 
a high pass filter (λ ≥ 540 nm) to cut out the excitation light, this fluorescence can be 
observed (Neuhaus et al., 2009). When a subsurface enamel lesion that is occupied by 
water is present, an increase in light scattering can be observed relative to the 
surrounding enamel producing two important effects (De Josselin et al., 1995, Neuhaus 
et al., 2009): 
1. Less excitation light reaches the dentin so that less fluorescence is produced 
underneath the lesion 
2. Fluorescence that occurs is scattered through the lesion so that less light is 
observed. 
De Josselin et al. (1995) developed a technique based on this optical phenomenon that 
was able to quantify the difference in fluorescence between intact and demineralised 
tooth structure. The currently marketed systems (Inspektor Research Systems BV, 
Amsterdam, The Netherlands) provide three quantitative metrics: 
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1. ΔF: Percentage fluorescence loss with respect to the fluorescence of sound tooth 
tissue; related to lesion depth (%), 
2. ΔQ: The ΔF times the Area. Percentage fluorescence loss with respect to the 
fluorescence of sound tissue times the area. Related to lesion volume (% px2), 
3. Area: The surface area of the lesion expressed in pixels2 (px2). 
The QLF system has been tested in several in vitro studies. Hafstrom-Bjorkman et al. 
(1992) compared light induced fluorescence with longitudinal microradiography, and 
found results that indicated a lower discrimination threshold for laser fluorescence 
compared to longitudinal microradiography. His results were further reinforced by Emami 
et al. (1996), who found that there was a high correlation coefficient (r=0.73) light 
induced fluorescence and longitudinal microradiography, and concluded that light 
induced fluorescence is sensitive and valid method for quantification of mineral loss in 
enamel caries lesions. Al-Khateeb et al. (1997b) validated the QLF device against 
microradiographic and chemical analysis for the assessment of mineral changes in 
enamel. 
Pretty et al. (2002b), looked at the intra- and inter-examiner reliability of QLF analysis. 
The authors concluded that the analysis stage of QLF is reliable between examiners and 
within multiple attempts by the same examiner, when analysing in vitro lesions. 
The QLF method has also displayed similar results when used in situ studies. Al-
Khateeb et al. (1997a) concluded that with the sensitive laser fluorescence method, it 
was possible to register the small changes in the enamel week by week during in situ 
remineralisation. he also found a highly significant linear dependence (p < 0.001) 
between the final measurements obtained with the laser fluorescence method and the 
data obtained from transverse microhardness, r = 0.76 which is considered to be the 
gold standard for the measurement of smooth surface enamel mineralisation. 
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Tranaeus et al. (2002) tested In vivo the repeatability and reproducibility of the QLF 
method with respect to three variables: lesion area, and average and maximum changes 
in lesion fluorescence. For the image-capturing stage, inter-examiner reliability showed 
an intra-class correlation coefficient (r) between 0.95 and 0.98. For the analytical stage, 
intra-examiner reliability for all three analysts showed a value of r between 0.93 and 
0.99. Inter-examiner reliability showed a value of r between 0.95 and 0.99. The authors 
concluded that the in vivo repeatability and reproducibility of the QLF method were 
excellent. 
One of the major limitations of the QLF method is that QLF readings can be affected with 
multiple factors, which include the presence of plaque, calculus and/or staining. The 
degree of dehydration of the tooth surface may also impact the readings obtained (Al-
Khateeb et al., 2002). Therefore, In order to achieve reliable results, the application of 
compressed air for 15 seconds prior to the QLF imaging is suggested (Pretty et al., 
2004). 
Another limitation for QLF is that manufacturer recommendations include taking images 
in a dark environment. This may be suitable for in vitro uses but when used in vivo this 
would be impractical. Pretty et al. (2002a) found that a light level of 88 lux could be 
employed in areas where QLF is to be used without significantly affecting the reported 
values. 
1.5.2 Indentation techniques 
Indentation techniques include both micro-hardness (George et al., 2015) and nano-
indentation techniques (Bertassoni et al., 2010). These methods have been used to 
measure the hardness of the tooth tissue using a diamond tip with known dimensions. 
The diamond tip is pressed against the tissue surface with a predetermined load (25-50 
g) and duration, and a measurement of the resistance of tooth tissue to the diamond tip 
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is given. Data is then produced in arbitrary units, usually Knoop hardness number or 
Vickers hardness number (George et al., 2015). 
The main criticism for this technique is that hardness increase is not identical to 
remineralisation, and that surface micro-harness measurements do not provide insight 
into mineral loss or gain nor do they detect redistribution of minerals within lesions 
following exposure to remineralising agents (Zero, 1995). However, surface micro-
hardness has been found to be a highly sensitive and reproducible method for studying 
the very early stages of enamel demineralisation and remineralisation (Zero, 1995). 
1.5.3 Transverse microradiography (TMR) 
‘Transverse microradiography (TMR) can be regarded as the gold standard for the 
evaluation of mineral distribution in cariology research.’ (Buzalaf et al., 2010). TMR or 
contact microradiography can be used to measure the morphology of and the change in 
mineral content of dental hard tissue. Furthermore it provides a quantitative 
measurement of the amount of mineral, lesion depth and surface layer thickness (Clasen 
and Ogaard, 1999). 
The limitation of this technique is that it is destructive to tooth tissue, and therefore 
studies looking at longitudinal mineral changes in the same lesions, cannot utilise this 
method (Nakata et al., 2012). 
To prepare samples for TMR investigation, thin slices approximately 80 µm for enamel 
samples are cut perpendicular to the enamel surface. Radiographic exposure of the 
sample alongside a calibration aluminium wedge, using high resolution film produces a 
microradiographic image. The mineral can be automatically calculated from the grey 
levels of the image compared to the step wedge. ΔZ is the parameter of interest and it 
reflects the amount of mineral lost (White et al., 1992). 
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The main advantages of this technique are accuracy of determination of mineral loss or 
gain and the ability to detect mineral distribution in the lesion (Arends and ten Bosch, 
1992). 
1.5.4 Microcomputed tomography (Micro-CT) 
A recently developed and promising method for assessment of demineralisation and 
remineralisation is microcomputed tomography (Micro-CT). Advantages of this technique 
are numerous and include Precise measurements and greater sensitivity to changes in 
mineral with time and position. More importantly, this method is non-destructive to tooth 
tissue and can be used to measure longitudinal changes in mineral content of dental 
tissues. Micro-CT also allows complementary analyses of fluoride, calcium and 
phosphorus present in the enamel (Buzalaf et al., 2010). 
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1.6 Research aims and hypotheses 
1.6.1 Aims: 
1. To investigate and compare the remineralising potential of toothpastes with  
different Fluoride (F) formulations: amine fluoride (AmF), sodium 
monofluorophosphate (MFP), sodium fluoride (NaF), and stannous fluoride (SnF) 
on artificial subsurface caries lesions  in vitro. 
2. To investigate and compare the remineralising potential of toothpastes containing 
sodium fluoride (NaF) formulation at different concentrations of fluoride (500, 
1000, 1450, 2800 and 5000 ppm F) on artificial subsurface caries lesions in vitro. 
 
1.6.2 The null hypotheses: 
1. There is no difference in the effect of toothpastes containing different fluoride 
formulations:  AmF, MFP, NaF and SnF on remineralisation of artificial 
subsurface carious lesions in vitro. 
2. There is no difference in the effect of toothpastes with sodium fluoride (NaF) 
formulation and different concentrations (500-5000 ppm F) on remineralisation of 
artificial subsurface carious lesions in vitro.
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Chapter 2 MATERIALS AND METHODS: 
This was a two phase  in vitro study design to investigate the remineralisation of the 
enamel subsurface lesions under pH cycling conditions using different fluoride 
formulations (phase A), and different NaF concentrations (phase B). The methodology 
adopted in the present study including preparation of tissue samples and the pH cycling 
protocol as well as the materials and equipment used will be described in this section. 
2.1 Power calculation: 
Statistical advice was sought and the sample size was calculated by using data from a 
previous professional Doctorate thesis ‘Comparison of the newer preventative therapies 
on remineralisation of enamel in vitro.’ (Bataineh, 2014), A total of 23 enamel slabs per 
group was needed. This calculation was based on the assumption that the standard 
deviation of the response variable is 2.03, power 95%, 0.05 significance level. This is 
based on calculations by UCSF Biostatistics: Power and Sample Size Programs.
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2.2 Experiment materials: Phase A 
1. Fluoride free toothpaste (0 ppm F) - Boots Smile Non Fluoride. 
 
Figure 1 Fluoride free toothpaste (0 ppm F) - Boots Smile Non Fluoride. 
 
2. Sodium Fluoride (NaF) toothpaste (1450 ppm F) – Colgate Total Original Care. 
 
Figure 2 Sodium Fluoride (NaF) toothpaste – Colgate Total Original Care.
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3. Stannous Fluoride (SnF) toothpaste (1450 ppm F) (1100 ppm SnF + 350 ppm 
NaF) – Oral-B Pro-Expert. 
 
Figure 3 Stannous Fluoride (SnF) toothpaste – Oral-B Pro-Expert. 
 
4. Sodium Monofluorophosphate (MFP) toothpaste (1450 ppm F) – Colgate 
Sensitive Pro-Relief™. 
 
Figure 4 Sodium Monofluorophosphate (MFP) toothpaste – Colgate Sensitive Pro-
Relief™.
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5. Amine Fluoride (AmF) toothpaste (1400 ppm F) – Elmex Kariesschutz. 
 
Figure 5 Amine Fluoride (AmF) toothpaste – Elmex Kariesschutz. 
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2.3 Experiment materials: Phase B 
1. Fluoride free toothpaste (0 ppm F) - Boots Smile Non Fluoride. 
 
Figure 6 Fluoride free toothpaste (0 ppm F) - Boots Smile Non Fluoride. 
 
2. 500 ppm F Sodium Fluoride (NaF) toothpaste – Fluocaril Kids 2 to 6. 
 
 
Figure 7 500 ppm F Sodium Fluoride (NaF) toothpaste – Fluocaril Kids 2 to 6.
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3. 1000 ppm F Sodium Fluoride (NaF) toothpaste – Aquafresh Milk Teeth 0-2. 
 
Figure 8 1000 ppm F Sodium Fluoride (NaF) toothpaste – Aquafresh Milk Teeth 0-2. 
 
4. 1450 ppm F Sodium Fluoride (NaF) toothpaste  – Colgate Total Original 
Care. 
 
Figure 9 1450 ppm F Sodium Fluoride (NaF) toothpaste  – Colgate Total Original 
Care.
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5. 2800 ppm F Sodium Fluoride (NaF) toothpaste – Colgate Duraphat 
0.619%W/W. 
 
Figure 10 2800 ppm F Sodium Fluoride (NaF) toothpaste – Colgate Duraphat 
0.619%W/W. 
 
6. 5000 ppm F Sodium Fluoride (NaF) toothpaste – Colgate Duraphat 1.1% 
W/W. 
 
Figure 11 5000 ppm F Sodium Fluoride (NaF) toothpaste – Colgate Duraphat 1.1% 
W/W
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2.4 Experimental and control groups 
The enamel slabs were randomly assigned to two phases, each phase containing a 
number of groups: 
2.4.1 Phase A: Different fluoride formulation toothpastes, with a 
fixed concentration, containing five groups: 
1. Fluoride free toothpaste (0 ppm F)  – 2 times/day (negative control). 
2. Sodium fluoride (NaF) toothpaste (1450 ppm F) – 2 times/day. 
3. Stannous Fluoride (SnF) toothpaste (1450 ppm F) (1100 ppm SnF + 350 ppm 
NaF) – 2 times/day. 
4. Sodium Monofluorophosphate (MFP) toothpaste (1450 ppm F) – 2 times/day. 
5. Amine Fluoride (AmF) toothpaste (1400 ppm F) – 2 times/day. 
2.4.2 Phase B: Different sodium fluoride (NaF) concentration 
toothpastes containing six groups: 
1. Fluoride free toothpaste (0 ppm F) – 2 times/day (negative control). 
2. 500 ppm F Sodium Fluoride (NaF) toothpaste – 2 times/day. 
3. 1000 ppm F Sodium Fluoride (NaF) toothpaste  – 2 times/day. 
4. 1450 ppm F Sodium Fluoride (NaF) toothpaste – 2 times/day. 
5. 2800 ppm F Sodium Fluoride (NaF) toothpaste – 2 times/day. 
6. 5000 ppm F Sodium Fluoride (NaF) toothpaste – 2 times/day. 
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2.5 Enamel slab preparation 
All enamel slabs used in the present study were obtained from bovine incisors. Approval 
for collection of bovine teeth was sought from the Food Standards Agency (Appendix 1) 
The teeth were obtained from an abattoir and stored immediately in distilled water and 
0.1% thymol (Sigma Aldrich) at room temperature. Before sectioning, the teeth were 
cleaned using a spoon excavator and a toothbrush with pumice powder to remove any 
soft tissue remnants. To detect any defects, caries or cracks, all teeth were screened by 
trans-illumination and transmitted light using a low-power microscopy (Leitz, Wetzlar®, 
Germany). Suitable teeth were selected for the study. 
 
Figure 12 Extracted bovine incisor 
 
Each tooth was mounted using ‘green stick’ impression compound (Kerr, UK) on plates. 
The crowns were sectioned using water cooled, diamond wire saw, cutting machine 
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(Well@Walter EBNER, CH-2400 Le Loche). The buccal and palatal surfaces of each 
crown were separated, and each buccal section was cut into three slabs that were 
approximately 6 x 5 x 3 mm in size.  
  
Figure 13 Diamond wire saw apparatus used for the teeth sectioning (Well® Walter 
EBNER, CH-2400 Le Loche). 
 
Each enamel slab was mounted on a plastic rod using “sticky wax” to hold the slab in the 
demineralising gel. The rod was secured to the lid of a “Sterilin” type universal tube so 
that when the top was screwed onto the tube, the tooth was suspended in the centre of 
the tube free space.  Two coats of an acid resistant, coloured nail varnish (Max Factor 
“Glossfinity”) were then applied on the enamel slabs, except for a small window of 
approximately 2 x 3 mm on the centre of each slab that was left exposed. An interval of 
24 hours was left between the two applications to allow the nail varnish to dry 
completely.   
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Figure 14 Maxfactor Glossinfinity (Red Passion 110) nail varnish. 
 
Once the enamel slabs were prepared, they were kept moist in plastic containers 
containing de-ionised water at room temperature to prevent dehydration. 
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Figure 15 Enamel slabs suspended in sterilin tubes painted with nail varnish 
laving an exposed enamel window. 
2.6 Preperation of the enamel sub-surface lesion: 
In order to obtain a sub-surface caries-like lesion an acid demineralising gel was 
prepared. Preparation of the demineralising system (acidified hydroxyethyl cellulose gel) 
was performed by adding 0.1 M sodium hydroxide (BDH Analar Grade) to 0.1 M lactic 
acid (Sigma Aldrich D/L GPR 87% Lactic acid) to give a pH value of 4.5 and then 6% w/v 
hydroxyethyl cellulose (Sigma Aldrich) was added to the solution and stirred for one hour 
until a consistency similar to that of “wallpaper paste” was achieved. The mixture was left 
to settle for 24 hours. Once the demineralising gel was ready for use, it was poured into 
the universal tubes “Sterilin” into which the mounted teeth were then submerged (Figure 
16). The enamel slabs were immersed in acid gel for 10 days to produce an artificial 
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enamel subsurface lesion. The enamel slabs were removed from the acid gel and 
washed with distilled water, the nail varnish was then removed using methanol to 
prepare the enamel slabs for the baseline QLF measurements. 
 
Figure 16 Enamel slab immersed in acidified hydroxyethyl cellulose gel. 
 
2.7 Quantitative light-induced fluorescence (QLF) 
measurements 
For each enamel slab, QLF measurements were taken after the creation of the enamel 
subsurface lesion and at the end of the 28 days experiment period using the QLF 
machine (QLF-D Biluminator™ 2) (Inspektor Research Systems BV, Amsterdam, The 
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Netherlands), Under controlled conditions.  All the slabs were dried for 15 seconds with 
compressed air prior to imaging, and were then examined in a dark room. 
QLF-D Biluminator™ 2 consists of a Biluminator™ mounted on a Single Lens Reflex 
(SLR) camera fitted with a 60 mm macro lens. The Biluminator™ provides the light 
sources and filters for making white-light and QLF™-images.  Fluorescence images of all 
enamel specimens were captured with a ‘Live View’-enabled digital full-sensor SLR 
camera (model 550D, Canon, Tokyo, Japan) at the following setting: shutter speed of 
1/30 s, aperture value of 6.7, and ISO speed of 1600. All digital images were stored 
automatically on a personal computer with image-capturing software (C3 version 1.16; 
Inspektor Research Systems). All ﬂuorescence images were examined with analysing 
software (QA2 version 1.16; Inspektor Research Systems). The analyses were 
performed by a single trained examiner. 
To ensure that images of the enamel slab were always captured in the same camera 
positions and from the same angles, the camera was attached to a stand in the same 
position for all the images. The QLF camera was fixed at a position that provided 
optimum illumination of the enamel block surface.  The camera specimen distance was 
standardised using the jig thereby controlling specimen stability light intensity and 
magnification.   
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Figure 17 QLF machine, the SLR camera attached to the stand with standardised 
distance from the enamel slab.  
 
A patch was drawn around the white spot lesion site by the study examiner with its 
borders on sound enamel (Figure 18). Inside this patch, the fluorescence levels of sound 
tissue were reconstructed by using the fluorescence radiance of the surrounding sound 
enamel. The percentage difference between the reconstructed and the original 
fluorescence levels was calculated. The same area of interest was used for the baseline 
and endpoint white spot lesion image identification. 
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Figure 18 : QLF image taken with the blue light shows the demineralised lesion in 
the centre of the enamel slab as well as a patch drawn around the lesion with 
the border in sound enamel. 
 
Demineralised areas appeared as dark spots. The fluorescent radiance of a white spot 
lesion viewed by QLF was lower than that of sound enamel. In order to enable 
calculation of loss of fluorescence in the white spot lesion, the fluorescent radiance of 
sound tissue at the lesion site was reconstructed by interpolation from the radiance of 
the sound tissue surrounding the lesion. Fluorescence radiance levels less than 95% of 
reconstructed sound fluorescence radiance levels were considered to be artificial early 
caries lesions and were displayed as shades of grey where darker grey corresponds to 
higher fluorescence loss. The difference between the measured values and the 
reconstructed values gave the resulting fluorescence loss in the lesion. 
For each enamel lesion the following three metrics were obtained: 
1. ΔF: Percentage fluorescence loss with respect to the fluorescence of sound tooth 
tissue; related to lesion depth (%). 
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2. ΔQ: The ΔF times the Area. Percentage fluorescence loss with respect to the 
fluorescence of sound tissue times the area. Related to lesion volume (% px2). 
3. Area: The surface area of the lesion expressed in pixels2 (px2). 
Example of the blue light image analysis results including ΔF, ΔQ and the lesion area 
values. 
 
Example of the blue light image of demineralised enamel lesions before and after pH 
cycling. 
 
Before lesion cycling                After lesion cycling 
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2.8 The ΔF range of the artificial lesions 
After performing the QLF baseline analysis for all enamel slabs, the range of ΔF values 
were found to vary between -5.97 and -32.53. The enamel slabs with the ΔF range (-8.57 
to -20.83 with an average of -13.28) were selected to be involved in the experiment in 
order to pick up the differences in ΔF after treatment. 
2.9 Randomisation and blindness 
All enamel slabs were randomly assigned to five groups in phase A, and six groups in 
phase B using a random number generator. When the slabs were analysed with QLF, 
the investigator did not know to which group the enamel slab belongs, making the 
analysis blinded. 
2.10 The pH cycling regime 
Each enamel slab was attached to a plastic rod (holder). The enamel slabs were rinsed 
with distilled water for 1 minute then dipped in toothpaste slurry for 5 minutes. After that 
the enamel slabs were rinsed with distilled water for 1 minute and placed in day time 
artificial saliva for 60 minutes. The enamel slabs were then exposed to the first 
demineralisation challenge by dipping in acetic acid solution (pH 4.8) for 5 minutes, then 
rinsed with distilled water for 1 minute and placed in day time artificial saliva. This 
process was repeated until the enamel slabs were subjected to 5 demineralisation 
challenges. After the last cycle the enamel slabs were dipped in toothpaste slurry for 5 
minutes. 
Enamel slabs were then places in night time artificial saliva. The acetic acid was 
changed after each exposure. The day time saliva and the night time saliva were 
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changed every day. The enamel slabs were kept in the incubator at 37˚C at all times 
except during the dipping in the toothpaste slurry or the demineralisation solution (Figure 
19). 
 
Figure 19 Enamel slabs were kept in incubator at 37˚C at all times except during 
the dipping in the toothpaste slurry or the demineralisation solution 
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2.11 Toothpaste slurry 
Toothpaste slurries were prepared by mixing the toothpaste with artificial day saliva in a 
volume ratio 1:4 (toothpaste: saliva) by weight, using a WhirliMixer® (Fisons) for 1 
minute. 
The toothpastes used were: 
Phase A: 
1. Fluoride free toothpaste (0 ppm F)  – 2 times/day (negative control). 
2. Sodium fluoride (NaF) toothpaste (1450 ppm F) – 2 times/day. 
3. Stannous Fluoride (SnF) toothpaste (1450 ppm F) – 2 times/day. 
4. Sodium Monofluorophosphate (MFP) toothpaste (1100 ppm SnF + 350 ppm NaF) 
– 2 times/day. 
5. Amine Fluoride (AmF) toothpaste (1400 ppm F) – 2 times/day. 
Phase B: 
1. Fluoride free toothpaste (0 ppm F) – 2 times/day (negative control) 
2. 500 ppm F Sodium Fluoride (NaF) toothpaste – 2 times/day. 
3. 1000 ppm F Sodium Fluoride (NaF) toothpaste  – 2 times/day. 
4. 1450 ppm F Sodium Fluoride (NaF) toothpaste – 2 times/day. 
5. 2800 ppm F Sodium Fluoride (NaF) toothpaste – 2 times/day. 
6. 5000 ppm F Sodium Fluoride (NaF) toothpaste – 2 times/day.
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2.12 Flow charts 
Flow chart for phase A-1: Different fluoride formulation toothpaste phase 
containing five groups (Fluoride-free, NaF, SnF, MFP, AmF): 
 
 
 
                                                   
 
 
 
 
Toothpaste slurry with 
different fluoride formulations 
for 5 min    (F-free, NaF, SnF, 
MFP, AmF) 
Distilled water 
for 1 min
Demineralising 
solution for 5 
min
Distilled water 
for 1 min
Daytime saliva 
for 60 min
Toothpaste slurry with 
different fluoride 
formulations for 5 min 
(F-free, NaF, SnF, MFP, 
AmF) 
 
Night time saliva 
5 times daily 
for 28 days 
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Flow chart for phase A-2: Different fluoride formulation toothpaste phase 
containing five groups (Fluoride-free, NaF, SnF, MFP, AmF): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Toothpaste slurry (Fluoride-free, NaF, SnF, MFP, AmF) for 5 min 
2. Acetic acid (for 5 min) 
 
1. Acetic acid (for 5 min) 
Wash with distilled water 
Toothpaste slurry (Fluoride-free, NaF, SnF, MFP, AmF) for 5 min 
 
 Night time saliva 
3. Acetic acid (for 5 min) 
 
5. Acetic acid (for 5 min) 
 
4. Acetic acid (for 5 min) 
 
Wash with distilled water --->60 min in day time saliva---Wash with distilled water 
Wash with distilled water --->60 min in day time saliva---Wash with distilled water 
Wash with distilled water --->60 min in day time saliva---Wash with distilled water 
Wash with distilled water --->60 min in day time saliva---Wash with distilled water 
Wash with distilled water--->60 min in day time saliva---Wash with distilled water 
Wash with distilled water --->60 min in day time saliva---Wash with distilled water 
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Flow chart for phase B-1: Different sodium fluoride (NaF) concentration 
toothpastes containing six groups (0 ppm, 500 ppm, 1000 ppm, 1450 ppm, 
2800 ppm, 5000 ppm): 
 
 
                                                   
 
 
 
 
 
 
 
NaF Toothpaste slurry 
with different fluoride 
concentrations for 5 min  
Distilled water 
for 1 min
Demineralising 
solution for 5 
min
Distilled water 
for 1 min
Daytime saliva 
for 60 min
NaF Toothpaste slurry 
with different fluoride 
concentrations for 5 
min  
 
Night time saliva 
5 times daily 
for 28 days 
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Flow chart for phase B-2: Different sodium fluoride (NaF) concentration 
toothpastes containing six groups (0 ppm, 500 ppm, 1000 ppm, 1450 ppm, 
2800 ppm, 5000 ppm): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NaF Toothpaste slurry (0 ppm, 500 ppm, 1000 ppm, 1450 ppm, 2800 ppm, 5000 ppm) for 5 min 
2. Acetic acid (for 5 min) 
 
2. Acetic acid (for 5 min) 
Wash with distilled water 
NaF Toothpaste slurry (0 ppm, 500 ppm, 1000 ppm, 1450 ppm, 2800 ppm, 5000 ppm) for 5 min 
 Night time saliva 
3. Acetic acid (for 5 min) 
 
5. Acetic acid (for 5 min) 
 
4. Acetic acid (for 5 min) 
 
Wash with distilled water --->60 min in day time saliva---Wash with distilled water 
Wash with distilled water --->60 min in day time saliva---Wash with distilled water 
Wash with distilled water --->60 min in day time saliva---Wash with distilled water 
Wash with distilled water --->60 min in day time saliva---Wash with distilled water 
Wash with distilled water--->60 min in day time saliva---Wash with distilled water 
Wash with distilled water --->60 min in day time saliva---Wash with distilled water 
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2.13 Preparations of solutions used in the study 
2.13.1 Artificial saliva 
Two artificial saliva solutions were used in this study. The first solution was used for day 
time during the pH cycling, between the acid exposures. The second solution was used 
to store the slabs during the night. The day saliva was supersaturated solution that 
allowed remineralisation of enamel slabs, the night saliva was a saturated solution that 
maintained the enamel condition and did not provide any minerals exchange.    
The artificial saliva composition was based on the electrolyte composition of natural 
saliva and it was advised to be used in order to eliminate any precipitation on the enamel 
surface (as provided by Dr R. P. Shellis, Department of Oral and Dental Science, 
University of Bristol, Bristol, UK).
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2.13.1.1 The preparation of day time artificial saliva 
The formulation of daytime saliva is shown in Table 1. 
Table 1 Day time saliva formulation. 
  Salt Concentration g/L 
Calcium carbonate 0.07 
Magnesium carbonate (hydrated basic) 0.019 
Potassium di-hydrogen phosphate 0.554 
HEPES buffer (acid form) 4.77 
Potassium chloride 2.24 
 
Using 900 mL distilled water 1.8 mL 1 mol/L HCL and above components are stirred 
using a shaker until it all dissolves. The pH will be adjusted to 6.8 by adding KOH 
solution that is made up to 1L with de-ionised water.
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2.13.1.2 The preparation of night time artificial saliva 
The formulation of the night time saliva is shown in Table 2. 
Table 2 Night time saliva formulation. 
Salt Concentration g/L 
Calcium carbonate 0.05 
Magnesium carbonate (hydrated basic) 0.019 
Potassium di-hydrogen phosphate 0.068 
HEPES buffer (acid form) 4.77 
Potassium chloride 2.24 
 
Again using 900 mL distilled water 1.4 mL 1 mol/L HCL and above components are 
stirred using a shaker until it all dissolves. The pH will be adjusted to 6.8 by adding KOH 
solution that is made up to 1L with de-ionised water. 
2.13.2 Acetic acid buffer 
The preparation of acetic acid solution was done according to ten Cate et al. (2006), the 
constitution of acetic acid is shown in Table 3. 
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Table 3 Acetic acid formulation. 
 
The above contents and 1 L distilled water were stirred using centrifuge until fully 
dissolved. The pH was adjusted using pH meter (ORION- model 920A) by adding KOH 
solution to reach pH 4.8. 
2.14 Training and calibration 
The study investigator had received training to use the QLF machine (QLF-D 
Biluminator™ 2) and was familiar with the QLF software before the study.  
The training was provided by the manufacturer (Inspektor Research Systems BV, 
Amsterdam, The Netherlands), and included the image capturing as well as image 
analysis. The investigator assessment of sound, demineralised enamel and the border of 
the lesion during image analysis were calibrated. 
2.15 Intra-examiner reproducibility 
The study investigator randomly retested 15% of the enamel slabs with the QLF at the 
end of the experiment. Intra-examiner reproducibility was tested using Intra-class 
Correlation Coefficient (ICC). 
Contents Concentration g/L 
Calcium chloride 1.665 g 
Potassium di-hydrogen phosphate 1.13 g 
Acetic acid 28.73 ml 
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2.16 Statistical analysis 
The data were analysed using SPSS statistical software package for windows version 
22.0. Descriptive statistics were used to calculate the mean, median, range, and 
standard deviation.   
The normality of the data distribution was assessed using Shapiro-Wilk test and 
Kolmogorov-Smirnov test. 
Paired sampled t-tests were performed to compare the changes in remineralisation at 
baseline and after treatment within the same group. 
One way ANOVA was used to compare between the five groups when the data were 
normally distributed, and Kruskal-Wallis Test was used when the data were not normally 
distributed. Furthermore, Bonferroni test was used to assess if there was any significant 
difference between each of the groups. The test also calculated the 95% confidence 
interval. The significance level was set at p <0.05.
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Chapter 3 RESULTS 
3.1 Quantitative Light-Induced Fluorescence (QLF) Results for 
phase A: Different Fluoride formulation toothpastes 
containing five groups (Fluoride-free, NaF, SnF, MFP, AmF) 
Three main parameters for QLF were statistically analysed, these were: 
 ΔF: Percentage fluorescence loss with respect to the fluorescence of 
sound tooth tissue. Related to lesion depth (%). 
 ΔQ: ΔF times the Area. Percentage fluorescence loss with respect to the 
fluorescence of sound tissue times the area. This is related to lesion 
volume (%px2). 
 Area: The surface area of the lesion expressed in pixels2 (px2). 
3.1.1 The mean fluorescence loss ΔF: 
The values of ΔF at baseline for all groups were checked to see if there was a difference 
between the groups. The normality tests (Shapiro-Wilk test and Kolmogorov-Smirnov 
test) were carried out to check the normality of the data (Appendix 2). The data were 
considered normally distributed if the p values from these tests were not statistically 
significant (p >0.05). p values for all groups  except for MFP, and NaF groups were not 
statistically significant therefore data was not considered to be normally distributed, and 
required a non-parametric test to assess baseline distribution of slabs. 
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The boxplot (Figure 20) for the distribution of the ΔF at the baseline, showing that all 
groups were similar in range with MFP having the least variation in ΔF compared to the 
other groups and containing a single outlier. 
 
Figure 20 Boxplot for the distribution of the ΔF values at baseline for all groups.  
Error bars represent SD, the line in the box of Box-and-whisker plot is the 
median value of the data. 
 
Kruskal-Wallis test (Table 4) was performed to assess if there was any statistically 
significant difference in ΔF values at the baseline between the lesions assigned to the 
five groups. No statistically significant difference was found. 
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Table 4 Kruskal-Wallis Test between groups for ΔF values at baseline 
 ΔF at Baseline 
Chi-Square 7.759 
df 4 
Asymptomatic Significance 0.101 
a. Kruskal Wallis Test 
b. Grouping Variable: Formulation 
 
3.1.1.1 Difference in ΔF within each group 
The ΔF mean values both at baseline and after treatment are shown in (Table 5). It can 
be seen that there was an improvement in ΔF values for all the groups in the study. 
Table 5 Mean values of ΔF at baseline and after treatment for all groups. 
Group 
Mean ΔF at 
baseline ± SD 
Mean ΔF 
after 
treatment ± 
SD 
Mean Difference in ΔF at 
baseline and after treatment ± 
SD 
F Free -13.623 ± 3.39 -11.412 ± 2.54 2.211 ± 3.98 
NaF -13.375 ± 3.93 -7.417 ± 2.50 5.957 ± 4.11 
SnF -13.517 ± 3.50 -8.479 ± 2.30 5.038 ± 4.30 
MFP -12.249 ± 2.95 -9.224 ± 2.14 3.024 ± 3.48 
AmF -14.688 ± 3.14 -12.999 ± 5.49 1.689 ± 5.65 
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(Figure 21) shows the change in the mean of ΔF at baseline and after treatment with the 
standard deviation for all groups. 
 
Figure 21 ΔF mean values at baseline and after treatment for all groups. 
 
To assess whether the change in ΔF at baseline and after treatment was significantly 
different within the same group, paired T-Test was used. The results of the paired T-Test 
are shown in (Table 6). 
It can be seen that there was a statistically significant improvement in the ΔF values after 
treatment compared with that at baseline in all groups except AmF (p <0.05). 
 
 
 
 
 
65 
 
Table 6 Paired sampled T-Test results for ΔF values at baseline and after 
treatment. 
 
Paired Differences 
Sig. 
(2-
tailed) Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
F Free 
 
 
ΔF at 
baseline 
– 
ΔF after 
treatment 
 
2.211 3.98 0.795 0.568 3.852 0.010* 
NaF 5.957 4.11 0.822 4.259 7.655 0.000* 
SnF 5.038 4.30 0.876 3.223 6.851 0.000* 
MFP 3.024 3.48 0.683 1.616 4.431 0.000* 
AmF 1.689 5.65 1.129 -0.641 4.020 0.148 
 
3.1.1.2 Difference in ΔF between all groups: 
The ΔF difference (change) was measured using the following formula:   
Difference in ΔF = ΔF after treatment - ΔF at baseline 
(Figure 22) shows the difference in ΔF in the five tested groups. In all groups the 
difference in ΔF was positive, meaning that there was decrease in ΔF (mean 
fluorescence loss) after treatment compared to that at baseline. The highest reduction in 
ΔF was seen in the NaF toothpaste group with a mean ΔF difference of (5.957 ± 4.11), 
closely followed by SnF Fluoride toothpaste group at a mean difference of (5.038 ± 
4.30). The group with the least amount of reduction in mean ΔF, and highest standard 
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deviation was the AmF toothpaste at (1.689 ± 5.65). MFP and F Free toothpaste groups 
had a mean difference of (3.024 ± 3.48) and  (2.211 ± 3.98) respectively (Table 7). 
 
Figure 22 Means of the difference in ΔF at baseline and after treatment of all 
groups. 
 
Table 7 Descriptive statistics for the difference in ΔF at baseline and after 
treatment for all groups. 
Group N Minimum Maximum Mean Median 
Std. 
Deviation 
F Free 25 -6.033 9.067 2.210 1.366 3.977 
NaF 25 -0.200 13.867 5.957 4.500 4.113 
SnF 24 -1.333 15.400 5.037 4.000 4.296 
MFP 26 -2.800 8.733 3.024 2.516 3.484 
AmF 24 -8.567 12.567 1.689 0.966 5.647 
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Determination of the normality of the data for Difference in ΔF 
In order to check if the ΔF differences between the baseline and after treatment were 
normally distributed, data normality test was carried out. This included Shapiro-Wilk test 
and Kolmogorov-Smirnov test. p value was not statistically significant therefore data was 
considered to be normally distributed (p >0.05). 
The boxplot (Figure 23) of difference in ΔF at baseline and after treatment showed 
normal distribution of data in all groups, with AmF tooth paste group having a very large 
standard deviation. 
 
Figure 23 Boxplot for the difference in ΔF at baseline and after treatment for all 
groups. 
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One way ANOVA test (Table 8) was performed to assess if the difference in ΔF was 
statistically significant between the five groups. It showed that the mean difference in ΔF 
was statistically significant between the groups (p <0.05). 
Table 8 One way ANOVA between groups for the difference in ∆F at baseline and 
after treatment. 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Between Groups 333.527 4 84.132 4.429 0.002* 
Within Groups 2279.322 120 18.994   
Total 2615.849 124    
 
In order to determine which groups were statistically significant different, pairwise 
comparisons were conducted using a Bonferroni test. The Bonferroni tests corrects for 
multiple testing. The results of the Bonferroni tests are shown in (Table 9).
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Table 9 Multiple comparisons of the difference in ∆F at baseline and after 
treatment between all test groups and control with Bonferroni correction. 
 
(I) 
Group 
(J) Group 
Mean 
Difference (I-
J) 
Std. 
Error 
Sig. 
95% Confidence 
Interval 
Lower 
Bound 
Upper 
Bound 
Free 
AmF 0.521 1.233 1.000 -3.004 4.047 
MFP -0.814 1.221 1.000 -4.305 2.678 
NaF -3.747 1.233 0.029* -7.272 -0.221 
SnF -2.827 1.245 0.250 -6.389 0.735 
NaF 
AmF 4.268 1.233 0.007* 0.743 7.793 
Free 3.747 1.233 0.029* 0.221 7.272 
MFP 2.933 1.221 0.178 -0.558 6.424 
SnF 0.920 1.245 1.000 -2.642 4.482 
SnF 
AmF 3.348 1.245 0.082 -0.214 6.910 
Free 2.827 1.245 0.250 -0.735 6.389 
MFP 2.013 1.234 1.000 -1.515 5.541 
NaF -0.920 1.245 1.000 -4.482 2.642 
MFP 
AmF 1.335 1.221 1.000 -2.156 4.826 
Free 0.814 1.221 1.000 -2.678 4.305 
NaF -2.933 1.221 0.178 -6.424 0.558 
SnF -2.013 1.234 1.000 -5.541 1.515 
AmF 
Free -0.521 1.233 1.000 -4.047 3.004 
MFP -1.335 1.221 1.000 -4.826 2.156 
NaF -4.268 1.233 0.007* -7.793 -0.743 
SnF -3.348 1.245 0.082 -6.910 0.214 
*. The mean difference is significant at the 0.05 level. 
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It can be seen that the mean difference in ΔF of the F Free toothpaste group is 
significantly lower than the mean difference in ΔF of the NaF toothpaste group, but this is 
not the case when compared with AmF, MFP, and SnF as there is no significance. 
As for the NaF group, its mean difference in ΔF is significantly higher than both AmF and 
F Free groups, but there is no significance when compared with MFP, and SnF groups. 
3.1.1.3 The percentage change in ΔF at baseline and after treatment 
(%ΔF) was calculated using the following formula: 
(Difference in ΔF at baseline and after treatment / ΔF at baseline) × 100 
(Figure 24) shows the % change in ΔF values for all groups which was highest in the NaF 
toothpaste group at 41.4% and lowest for both F Free and AmF toothpaste groups 11.7% 
and 9% respectively. As for the SnF and MFP they were at 32.8% and 21.1% 
respectively. 
 
 
71 
 
 
Figure 24 The % ΔF values for all groups. 
 
Determination of the normality of data for Percentage reduction in ΔF: 
In order to check if the percentage in reduction of ΔF was normally distributed, data 
normality test was carried out. This included Shapiro-Wilk test and Kolmogorov-Smirnov 
test. P value was statistically significant therefore data was not considered normally 
distributed (p<0.05). 
The Boxplot (Figure 25) of the percentage of reduction in ΔF showed two outliers in the 
NaF group and a median indicating greater percentage reduction. All other groups were 
similar in medians, with similar standard deviations and no outliers. 
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Figure 25 Boxplot for the Percentage of reduction in ΔF for all groups. 
 
Non parametric Kruskal-Wallis test (Table 10) was performed to assess if the percentage 
reduction in ΔF was statistically significant between the five groups. It showed that the 
mean percentage reduction of ΔF was statistically significant between groups (p<0.05). 
 
 
 
 
 
73 
 
Table 10 Kruskal-Wallis Test results for the Percentage of reduction in ΔF. 
 Percentage of reduction in ΔF 
Chi-Square 18.043 
df 4 
Asymp. Sig. .001 
a. Kruskal Wallis Test 
b. Grouping Variable: Formulation 
 
In order to determine which groups were statistically significant different, pairwise 
comparison was performed (Figure 26). The test showed that NaF had a significantly 
higher percentage of reduction in ΔF when compared to AmF and F Free groups 
(p<0.05). No other significant differences were found. 
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Figure 26 Pairwise comparison between percentages of reduction in ΔF between 
all formulations 
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3.1.1.4 Intra-examiner reproducibility for ΔF 
The intra-examiner reproducibility was tested using intra-class correlation coefficient. 19 
enamel slabs (15%) were randomly selected and re-analysed. The Intra-class correlation 
coefficient (Table 11) was found to be (0.99) which represents excellent reproducibility. 
Table 11 Intra-class Correlation Coefficient for ΔF measurements. 
 Intra-class 
Correlation 
95% Confidence 
Interval 
F Test with True Value 0 
Lower 
Bound 
Upper 
Bound 
Value df1 df2 Sig 
Single 
Measures 
.989 .978 .994 176.103 19 19 .000 
Average 
Measures 
.994 .989 .997 176.103 19 19 .000 
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3.1.2 ΔQ: ΔF times the Area. Percentage fluorescence loss with 
respect to the fluorescence of sound tissue times the area. 
Lesion volume 
Normality tests (Shapiro-Wilk test and Kolmogorov-Smirnov test) were done for the ΔQ 
values at baseline and showed that the data were normally distributed for all groups 
(Appendix 3). 
The boxplot (Figure 27) for the distribution of the ΔQ at the baseline showed similar 
distribution of medians between the groups. AmF and F Free toothpaste groups had a 
larger standard deviation than the rest of the groups. 
 
Figure 27 Boxplot for the distribution of the ΔQ values at baseline for all groups. 
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One way ANOVA test (Table 12) was performed to assess if there was any statistically 
significant difference in ΔQ at the baseline between the lesions assigned to the five 
groups. No statistically significant difference was found. 
Table 12 One way ANOVA results for ΔQ values at baseline. 
 Sum of Squares df Mean Square F Sig. 
Between 
Groups 
6.53E+8 4 1.63E+8 1.057 0.381 
Within Groups 1.9E+10 120 1.54E+8   
Total 1.9E+10     
3.1.2.1 Difference in ΔQ within each group 
The ΔQ mean values both at baseline and after treatment are shown in (Table 13).  It 
can be seen that there was an improvement in ΔQ values for all the groups in the study. 
Table 13 The mean values of ΔQ at baseline and after treatment for all groups. 
Group Mean ΔQ at 
baseline ± SD 
Mean ΔQ 
after 
treatment ± 
SD 
Mean Difference in ΔQ at 
baseline and after treatment ± 
SD 
F Free -26468.027 ± 
14321.27 
-19435.373 ± 
8249.20 
7032.653 ± 13554.28 
NaF -23800.893 ± 
11342.64 
-852.733 ± 
957.35 
22948.160 ± 10979.76 
SnF -26468.292 ± 
12189.41 
-8936.972 ± 
7830.86 
17531.319 ± 12108.89 
MFP -21548.813 ± 
11257.30 
-7290.731 ± 
7129.00 
14258.082 ± 12823.84 
AmF -27872.920 ± 
12803.14 
-22636.520 ± 
13429.10 
5236.400 ± 18679.27 
 
 
 
78 
 
(Figure 28) shows the change in the mean of ΔQ at baseline and after treatment with the 
standard deviation for all groups. 
 
Figure 28 ΔQ mean values at baseline and after treatment for all groups. 
 
To assess whether the change in ΔQ at baseline and after treatment was significantly 
different within the same group, paired T-Test was carried out and the results (Table 14) 
showed that there was a statistically significant improvement in the ΔQ values after 
treatment compared with that at baseline in Naf, SnF and MFP toothpaste groups (p 
<0.001), but there was no such significance in the AmF and F Free groups. 
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Table 14 Paired sampled T-Test results for ΔQ values at baseline and after 
treatment. 
 
Paired Differences 
Sig. 
(2-
tailed
) 
Mean 
Std. 
Deviatio
n 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
F 
Free  
 
ΔQ at 
baseli
ne 
– 
ΔQ 
after 
treatm
ent 
 
7032.65
3 
13554.2
8 
2710.85
6 
1437.72
1 
12627.5
9 
0.16 
NaF 
22948.1
6 
10979.7
6 
2195.95
3 
18415.9
4 
27480.3
8 
0.000
* 
SnF 
17531.3
2 
12108.8
9 
2471.71
7 
12418.1
8 
22644.4
5 
0.000
* 
MFP 
14258.0
8 
12823.8
4 
2514.96
1 
9078.42
2 
19437.7
4 
0.000
* 
AmF 
5236.40
0 
18679.2
7 
3735.85
4 
-
2474.02 
12946.8
2 
0.174 
 
3.1.2.2 Difference in ΔQ between groups 
The ΔQ difference (change) was measured using the following formula:   
Difference in ΔQ = ΔQ after treatment - ΔQ at baseline 
(Figure 29) shows the difference in ΔQ in the five tested groups. In all groups the 
difference in ΔQ was positive, meaning that there was decrease in ΔQ after treatment 
compared to that at baseline. The highest reduction  in ΔQ was in the NaF toothpaste 
group with a mean difference of  22948.160 ± 10979.76, while the lowest reduction was 
in the AmF group with only 5236.400 ± 18679.27 mean difference. 
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Figure 29 Means of the difference in ΔQ at baseline and after treatment of all 
groups. 
 
Table 15 Descriptive statistics for the difference in ΔQ at baseline and after 
treatment for all groups. 
Group N Minimum Maximum Mean Median 
Std. 
Deviatio
n 
F Free 25 -10204.333 37578.667 
7032.6
5333 
4418.000
0 
13554.28
0763 
NaF 25 7813.667 44060.667 
22948.
16000 
20896.33
333 
10979.76
3462 
SnF 24 -1785.333 41874.667 
17531.
31944 
15983.33
333 
12108.88
8777 
MFP 26 -10580.000 32893.000 
14258.
08205 
16264.66
667 
12823.83
7482 
AmF 24 -26172.333 38388.333 
5236.4
0000 
6833.000
00 
18679.26
7525 
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Determination of the normality of the data 
Shapiro-Wilk test and Kolmogorov-Smirnov test was carried out to check if the difference 
in ΔQ at baseline and after treatment was normally distributed. The data was considered 
normally distributed, as there was no statistical significance. 
The boxplot (Figure 30) of difference in ΔQ at baseline and after treatment shows similar 
Medians of AmF and F Free groups, both at a lower level than MFP, NaF and SnF 
which also have similar median level. The standard deviation for the AmF group is also 
very wide. 
 
Figure 30 Boxplot for the difference in ΔQ at baseline and after treatment for all 
groups. 
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One way ANOVA test (Table 16) was performed to assess if the difference in ΔQ was 
statistically significant between the five groups. It showed that the mean difference in ΔQ 
was statistically significant between the groups (p <0.001). 
Table 16 One way ANOVA between groups for the difference in ∆Q at baseline and 
after treatment. 
 Sum of Squares df Mean Square F Sig. 
Between Groups 5387564560.720 4 1346891140.180 6.979 .000* 
Within Groups 23160179936.438 120 193001499.470   
Total 28547744497.158 124    
 
In order to determine which groups were statistically significant different, pairwise 
comparisons were conducted using Bonferroni test. The Bonferroni tests corrects for 
multiple testing. The results of the Bonferroni tests are shown in (Table 17). It can be 
seen that the mean difference in ΔQ of the F Free toothpaste group is significantly lower 
than the mean difference in ΔQ of the NaF toothpaste group but this is not the case 
when compared with AmF, MFP, and SnF as there is no significance. 
As for the NaF group, its mean difference in ΔQ is significantly higher than AmF, and F 
Free groups only. 
SnF group had statistically higher mean difference in ΔQ than AmF group only. 
Mean difference in ΔQ for the MFP group was not statistically significant when compared 
to all other groups. 
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Table 17 Multiple comparisons of the difference in ∆Q at baseline and after 
treatment between all test groups and control. 
(I) 
Group 
(J) 
Group 
Mean Difference (I-
J) 
Std. Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Free 
AmF 1796.253333 3929.391805 1.000 -9441.27617 13033.78283 
MFP -7225.428718 3891.425776 .658 -18354.38051 3903.52307 
NaF -15915.506667* 3929.391805 .001* -27153.03617 -4677.97717 
SnF -10498.666111 3970.111979 .093 -21852.64980 855.31758 
NaF 
AmF 17711.760000* 3929.391805 .000* 6474.23050 28949.28950 
Free 15915.506667* 3929.391805 .001* 4677.97717 27153.03617 
MFP 8690.077949 3891.425776 .274 -2438.87384 19819.02974 
SaF 5416.840556 3970.111979 1.000 -5937.14314 16770.82425 
SnF 
AmF 12294.919444* 3970.111979 .024* 940.93575 23648.90314 
Free 10498.666111 3970.111979 .093 -855.31758 21852.64980 
MFP 3273.237393 3932.539096 1.000 -7973.29293 14519.76772 
NaF -5416.840556 3970.111979 1.000 -16770.82425 5937.14314 
MFP 
AmF 9021.682051 3891.425776 .221 -2107.26974 20150.63384 
Free 7225.428718 3891.425776 .658 -3903.52307 18354.38051 
NaF -8690.077949 3891.425776 .274 -19819.02974 2438.87384 
SnF -3273.237393 3932.539096 1.000 -14519.76772 7973.29293 
AmF 
Free -1796.253333 3929.391805 1.000 -13033.78283 9441.27617 
MFP -9021.682051 3891.425776 .221 -20150.63384 2107.26974 
NaF -17711.760000* 3929.391805 .000* -28949.28950 -940.93575 
SnF -12294.919444* 3970.111979 .024* -23648.90314 -940.93575 
*. The mean difference is significant at the 0.05 level. 
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3.1.2.3 The percentage of the changes in ΔQ at baseline and after 
treatment (%ΔQ) was calculated using the following formula: 
(Difference in ΔQ at baseline and after treatment / ΔQ at baseline) × 100 
(Figure 31) shows the % ΔQ change values for all groups with NaF group having near 
100% reduction in ΔQ, while AmF shows a negative reduction percentage -1%. AmF 
group was also showing a very low percentage reduction at 3.1%. SnF and MFP were at 
53.8% and 31.8% respectively. 
 
Figure 31 The %ΔQ values for all groups. 
 
Determination of the normality of data for Percentage reduction in ΔQ: 
In order to check if the percentage in reduction of ΔQ was normally distributed, data 
normality test was carried out. This included Shapiro-Wilk test and Kolmogorov-Smirnov 
test. P value was statistically significant therefore data was not considered normally 
distributed (p<0.001). 
 
 
85 
 
The Boxplot (Figure 32) of the percentage of reduction in ΔQ for all groups shows that 
the data is not normally distributed, and that there are several outliers in all groups 
except AmF group. Also noticeable, was the very narrow distribution of data in the NaF 
group (most of the data was clustered around the median), which was showing a very 
high percentage of reduction in ΔQ. 
 
Figure 32 Boxplot for the Percentage of reduction in ΔQ for all groups. 
 
Non parametric Kruskal-Wallis test (Table 18) was performed to assess if the percentage 
reduction in ΔQ was statistically significant between the five groups. It showed that the 
mean percentage reduction of ΔQ was statistically significant between groups (p<0.001). 
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Table 18 Kruskal-Wallis Test results for the Percentage of reduction in ΔQ. 
 Percentage of reduction in ΔQ 
Chi-Square 64.602 
df 4 
Asymp. Sig. 0.000 
a. Kruskal Wallis Test 
b. Grouping Variable: Formulation 
 
In order to determine which groups were statistically significant different, pairwise 
comparison was performed (). NaF group had a statistically higher mean percentage of 
reduction in ΔQ when compared to all other groups (p<0.05). MFP group also had a 
statistically higher mean percentage of reduction in ΔQ when compared to F Free group 
only (p<0.05). There was no further statistical significance in any other group. 
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Figure 33 Pairwise comparison between percentages of reduction in ΔQ between 
all formulations 
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3.1.2.4 Intra-examiner reproducibility for ΔQ 
The intra-examiner reproducibility was tested using intra-class correlation coefficient. 19 
enamel slabs (15%) were randomly selected and re-analysed. The Intra-class 
Correlation Coefficient (Table 19) was found to be (0.99) which  represents excellent 
reproducibility. 
Table 19 Intra-class Correlation Coefficient for ΔQ measurements. 
 
Intra-class 
Correlation 
95% Confidence 
Interval 
F Test with True Value 0 
Lower 
Bound 
Upper 
Bound 
Value df1 df2 Sig 
Single 
Measures 
.989 .978 .994 174.246 19 19 .000 
Average 
Measures 
.994 .989 .997 174.246 19 19 .000 
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3.1.3 Area of the white spot lesion 
The values of the white spot lesion area at baseline for all groups were checked to see if 
there was a difference between the groups. The normality tests (Shapiro-Wilk test and 
Kolmogorov-Smirnov test) showed that the data were normally distributed (Appendix 4). 
The boxplot (Figure 34) for the distribution of the area of white spot lesion at the baseline 
showed very close median values for all groups with one outlier in the SnF group. The 
Standard deviation range for AmF, F Free and MFP groups was also similar. NaF Group 
had the narrowest standard deviation of all groups. 
 
Figure 34 Boxplot for the distribution of the Area values at baseline for all groups. 
 
 
 
90 
 
One way ANOVA test (Table 20) was performed to assess if there was any statistically 
significant difference in the area values at the baseline between the lesions assigned to 
the five groups. No statistically significant difference was found. 
Table 20 One way ANOVA results for Area values at baseline. 
 Sum of Squares df Mean Square F Sig. 
Between 
Groups 
285761.4 4 71440.34 0.150 0.963 
Within Groups 5.71E+7 120 475586.5   
Total 5.74E+7 124    
 
3.1.3.1 Difference in lesion area within each group 
The lesion area mean values both at baseline and after treatment are shown in (Table 
21). It can be seen that there was a decrease in the lesion area for all groups in the 
study.
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Table 21 Mean values of Area at baseline and after treatment for all groups. 
Group 
Mean Area at 
baseline ± SD 
Mean Area 
after 
treatment ± 
SD 
Mean Difference in Area at 
baseline and after treatment ± 
SD 
F Free 
1869.253 ± 
714.61 
1683.200 ± 
576.10 
-186.053 ± 502.14 
NaF 
1778.693 ± 
575.41 
98.987 ± 
104.45 
-1679.707 ± 548.76 
SnF 
1842.736 ± 
668.68 
879.333 ± 
628.24 
-963.403 ± 879.51 
MFP 
1743.936 ± 
760.12 
710.051 ± 
617.68 
-1033.885 ± 991.53 
AmF 
1849.400 ± 
711.20 
1639.707 ± 
544.75 
-209.693 ± 788.68 
 
(Figure 35) shows the change in the mean of area at baseline and after treatment with 
the standard deviation for all groups. 
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Figure 35 Lesion area at baseline and after treatment for all groups. 
 
To assess whether the change in the area at baseline and after treatment was 
significantly different within the same group, paired T-Test was used. 
The paired T-Test results shown in (Table 22) showed that there was a statistically 
significant improvement in the lesion area values after treatment compared with that at 
baseline in NaF, SnF and MFP toothpaste test groups (p <0.001), while there was no 
significant difference between baseline and after treatment in the AmF test group and F 
Free control group. 
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Table 22 Paired sampled T test results for the lesion area values at baseline and 
after treatment for all groups. 
 
Paired Differences 
Sig. 
(2-
tailed) Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
F Free 
 
 
Area at 
baselin
e 
– 
Area 
after 
treatme
nt 
 
-
186.053 
502.1382 100.4276 
-
393.326 
21.21913 0.76 
NaF 
-
1679.71 
548.7572 109.7514 
-
1906.22 
-1453.19 0.000* 
SnF 
-
963.403 
879.5119 179.5296 
-
1334.79 
-592.017 0.000* 
MFP 
-
1033.88 
991.5311 194.4553 
-
1434.37 
-633.397 0.000* 
AmF 
-
209.693 
788.6843 157.7369 
-
535.246 
115.8595 0.196 
 
3.1.3.2 Difference in lesion area between groups 
The lesion area difference (change) was measured using the following formula:   
Difference in lesion area= lesion area after treatment – lesion area at baseline 
(Figure 36) shows the difference in the lesion area for the five tested groups. In all test 
groups, the mean difference was negative indicating a decrease in area of the lesion 
after treatment compared to that at baseline. 
The highest reduction in area size was found in the NaF toothpaste group -1679.707 ± 
548.76. SnF and MFP showed similar reduction in lesion size -963.403 ± 879.51 and -
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1033.885 ± 991.53 respectively. The lowest reduction in lesion size was in the F Free 
group -186.053 ± 502.14 followed by the AmF group at a mean difference of -209.693 ± 
788.68. 
 
Figure 36 Means of the difference in the lesion area at baseline and after treatment 
of all tested groups. 
 
Table 23 Descriptive statistics for the difference in Lesion Area at baseline and 
after treatment for all groups. 
Group N Minimum Maximum Mean Median 
Std. 
Deviation 
F Free 25 
-
1312.667 
600.667 -186.05333 -130.33333 502.138212 
NaF 25 
-
2804.333 
269.667 
-
1679.70667 
-
1751.66667 
548.757210 
SnF 24 
-
2804.333 
269.667 -963.40278 -657.00000 879.511947 
MFP 26 
-
3249.000 
1189.667 
-
1033.88462 
-
1192.33333 
991.531134 
AmF 25 
-
1791.667 
979.667 -209.69333 -223.66667 788.684282 
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Determination of the normality of lesion area difference at baseline and after 
treatment data: 
In order to check if the differences in the lesion area at baseline and after treatment were 
normally distributed, data normality test was carried out. This included Shapiro-Wilk test 
and Kolmogorov-Smirnov test. The data was considered normally distributed as there 
was no significance. 
The boxplot (Figure 37) of difference in the lesion area at baseline and after treatment 
shows similar range of median values for all groups with the MFP group having the 
widest standard deviation. 
 
Figure 37 Boxplot for the difference in the lesion Area at baseline and after 
treatment for all groups 
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One way ANOVA test (Table 24) was performed to assess if the difference in area was 
statistically significant between the five groups. It showed that the mean difference in 
area was statistically significant between the groups (p <0.001). 
Table 24 One way ANOVA between groups for the difference in Area at baseline 
and after treatment. 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Between Groups 39516424.245 4 9879106.061 16.797 .000* 
Within Groups 70577002.631 120 588141.689   
Total 110093426.876 124    
 
In order to determine which groups were statistically significant different, pairwise 
comparisons were conducted using Bonferroni test. The Bonferroni tests corrects for 
multiple testing. The results of the Bonferroni tests are shown in (Table 25). The mean 
reduction in Area of the lesion was significantly higher in the NaF group when compared 
to all other groups. 
The mean reduction in area for the F Free group was statistically lower than all other 
groups except for the AmF group. 
There was no significance when comparing SnF and MFP groups.
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Table 25 Multiple comparisons of the difference in Area at baseline and after 
treatment between all test groups and control. 
(I) 
Group 
(J) 
Group 
Mean Difference 
(I-J) 
Std. Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Free 
AmF 23.640000 216.913197 1.000 -596.70243 643.98243 
MFP 847.831282* 214.817368 .001* 233.48264 1462.17992 
NaF 1493.653333* 216.913197 .000* 873.31091 2113.99576 
SnF 777.349444* 219.161062 .006* 150.57843 1404.12046 
NaF 
AmF -1470.013333* 216.913197 .000* -2090.35576 -849.67091 
Free -1493.653333* 216.913197 .000* -2113.99576 -873.31091 
MFP -645.822051* 214.817368 .032* 1260.17069 -31.47341 
SnF -716.303889* 219.161062 .014* -1343.07491 -89.53287 
SnF 
AmF -753.709444* 219.161062 .008* -1380.48046 -126.93843 
Free -777.349444* 219.161062 .006* --1404.12046 -150.57843 
MFP 70.481838 217.086936 1.000 -550.35746 691.32114 
NaF 716.303889* 219.161062 .014* 89.53287 1343.07491 
MFP 
AmF -824.191282* 214.817368 .002* -1438.53992 -209.84264 
Free -847.831282* 214.817368 .001* -1462.17992 -233.48264 
NaF 645.822051* 214.817368 .032* 31.47341 1260.17069 
SnF -70.481838 217.086936 1.000 -691.32114 550.35746 
AmF 
Free -23.640000 216.913197 1.000 -643.98243 596.70243 
MFP 824.191282* 214.817368 .002* 209.84264 1438.53992 
NaF 1470.013333* 216.913197 .000* 849.67091 2090.35576 
SnF 753.709444* 219.161062 .008* 126.93843 1380.48046 
*. The mean difference is significant at the 0.05 level. 
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3.1.3.3 The percentage change in lesion area at baseline and after 
treatment (% Area) was calculated using the following formula: 
(Difference in area at baseline and after treatment / area at baseline) × 100 
(Figure 38) shows the % Area values for all groups, with NaF group having the highest % 
reduction in area of lesion 94.4%, followed by SnF and MFP Groups at 37.6% and 
24.5% respectively. The lowest % reduction in area was located in the F Free Group at 
0.1% followed closely by AmF group at 1.4%. 
 
Figure 38 The % Area values for all groups. 
 
Determination of the normality of data for Area: 
In order to check if the percentage in reduction of area was normally distributed, data 
normality test was carried out. This included Shapiro-Wilk test and Kolmogorov-Smirnov 
test. P value was statistically significant therefore data was not considered normally 
distributed (p<0.001). 
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The Boxplot (Figure 39) of the percentage of reduction in Area for all groups shows that 
the data is not normally distributed, and that there are several outliers in all groups. Also 
noticeable, was the very narrow distribution of data in the NaF group (most of the data 
was clustered around the median), which was showing a very high percentage of 
reduction in Area. 
 
Figure 39 Boxplot for the Percentage of reduction in Area for all groups. 
 
Non parametric Kruskal-Wallis test (Table 26) was performed to assess if the percentage 
reduction in area was statistically significant between the five groups. It showed that the 
mean percentage reduction of area was statistically significant between groups 
(p<0.001). 
 
 
100 
 
 
Table 26 Kruskal-Wallis Test results for the Percentage of reduction in Area. 
 Percentage of reduction in Area 
Chi-Square 68.470 
df 4 
Asymp. Sig. 0.000 
a. Kruskal Wallis Test 
b. Grouping Variable: Formulation 
 
In order to determine which groups were statistically significant different, pairwise 
comparison was performed (Figure 40). NaF group had a statistically higher mean 
percentage of reduction in Area when compared to all other groups (p<0.05). MFP group 
also had a statistically higher mean percentage of reduction in Area when compared to 
AmF, and F Free groups (p<0.05). There was no further statistical significance in any 
other group. 
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Figure 40 Pairwise comparison between percentages of reduction in Area between 
all formulations. 
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3.1.3.4 Intra-examiner reproducibility for Area of the white spot lesion 
The intra-examiner reproducibility was tested using intra-class correlation coefficient. 19 
enamel slabs (15%) were randomly selected and re-analysed. The Intra-class 
Correlation Coefficient (Table 27) was found to be (0.99) which  represents excellent 
reproducibility. 
Table 27 Intra-class Correlation Coefficient for Area measurements. 
 
Intra-class 
Correlation 
95% Confidence 
Interval 
F Test with True Value 0 
Lower 
Bound 
Upper 
Bound 
Value df1 df2 Sig 
Single 
Measures 
.992 .983 .996 230.060 19 19 .000 
Average 
Measures 
.996 .992 .998 230.060 19 19 .000 
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3.1.4 Summary of the results for all three parameters for phase A: 
The ΔF results: the results showed that there was statistically significant improvement in 
the ΔF values between baseline and after treatment for all groups except AmF group. 
The greatest improvement was seen in the NaF toothpaste group, closely followed by 
SnF toothpaste group, then MFP and finally fluoride free. 
When comparing the groups against each other, the difference in ΔF at baseline and 
after treatment in NaF group was statistically significantly higher than F Free and AmF 
groups. No other statistical significance was found. 
The ΔQ results: A statistically significant improvement in the ΔQ values between 
baseline and after treatment was found in NaF, SnF and MFP toothpaste groups, but 
there was no such significance in the AmF and F Free groups. The highest improvement 
was achieved by the NaF  group followed by the SnF and finally the MFP group. 
When comparing the groups against each other, the difference in ΔQ at baseline and 
after treatment was statistically significantly higher in the NaF group when compared to 
AmF and F Free toothpaste groups only. SnF group was significantly higher than AmF 
group only. No other statistical significance could be found. 
For the lesion area results: A significant reduction in the area of the white spot lesion 
was seen in the NaF, MFP and SnF groups in descending order. Reduction in area of 
lesion for the AmF and F Free groups was not significant. 
When comparing the groups against each other, the difference in the lesion area at 
baseline and after treatment was statistically significant in NaF group when compared to 
all other groups. All groups showed statistical significance when compared to F Free 
group except AmF group. There was no statistical significance between SnF and MFP 
groups. 
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3.2 Quantitative Light-Induced Fluorescence (QLF) Results for 
phase B: Different Sodium fluoride (NaF) concentration 
toothpastes containing six groups (0 ppm, 500 ppm, 1000 
ppm, 1450 ppm,  2800 ppm, 5000 ppm) 
Three main parameters for QLF were statistically analysed, these were: 
 ΔF: Percentage fluorescence loss with respect to the fluorescence of 
sound tooth tissue. Related to lesion depth (%). 
 ΔQ: ΔF times the Area. Percentage fluorescence loss with respect to the 
fluorescence of sound tissue times the area. This is related to lesion 
volume (%px2). 
 Area: The surface area of the lesion expressed in pixels2 (px2). 
3.2.1 The mean fluorescence loss ΔF: 
The values of ΔF at baseline for all groups were checked to see if there was a difference 
between the groups. The normality tests (Shapiro-Wilk test and Kolmogorov-Smirnov 
test) were carried out to check the normality of the data (Appendix 5). The data were 
considered normally distributed if the p values from these tests were not statistically 
significant (p >0.05). p values for 500 ppm, 1450 ppm, and 5000 ppm groups were 
statistically significant, therefore data was not considered to be normally distributed, and 
required a non-parametric test to assess baseline distribution of slabs. 
The boxplot (Figure 41) for the distribution of ΔF at the baseline showing that the 5000 
ppm group was heavily skewed, while all the other groups were somewhat similar in 
distribution. 
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Figure 41 Boxplot for the distribution of the ΔF values at baseline for all groups.  
Error bars represent SD, the line in the box of Box-and-whisker plot is the 
median value of the data. 
 
Kruskal-Wallis test (Table 28) was performed to assess if there was any statistically 
significant difference in ΔF values at the baseline between the lesions assigned to the six 
groups. No statistically significant difference was found. 
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Table 28 Kruskal-Wallis Test between groups for ΔF values at baseline 
 ΔF at Baseline 
Chi-Square 5.803 
df 5 
Asymptomatic Significance 0.326 
a. Kruskal Wallis Test 
b. Grouping Variable: Formulation 
 
3.2.1.1 Difference in ΔF within each group 
The ΔF mean values both at baseline and after treatment are shown in (Table 29).  It can 
be seen that there was an improvement in ΔF values for all the groups in the study.
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Table 29 The mean values of ΔF at baseline and after treatment for all groups. 
Group Mean ΔF at 
baseline ± SD 
Mean ΔF 
after 
treatment ± 
SD 
Mean Difference in ΔF at 
baseline and after treatment ± 
SD 
0 ppm -13.623 ± 3.39 -11.412 ± 2.54 2.211 ± 3.98 
500 ppm -13.504 ± 3.17 -7.553 ± 2.51 5.951 ± 3.81 
1000 ppm -12.641 ± 3.22 -7.899 ± 2.24 4.742 ± 3.44 
1450 ppm -13.375 ± 3.93 -7.417 ± 2.50 5.957 ± 4.11 
2800 ppm -13.740 ± 3.63 -7.879 ± 1.95 5.860 ± 3.84 
5000 ppm -12.160 ± 3.63 -6.700 ± 1.95 5.460 ± 3.78 
 
(Figure 42) shows the change in the mean of ΔF at baseline and after treatment with the 
standard deviation for all groups. 
 
Figure 42 ΔF mean values at baseline and after treatment for all groups. 
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To assess whether the change in ΔF at baseline and after treatment was significantly 
different within the same group, paired T-Test was used. The results of the paired T-Test 
are shown in (Table 30). 
It can be seen that there was a statistically significant improvement in the ΔF values after 
treatment compared with that at baseline in all groups (p <0.001). 
Table 30 Paired sampled T-Test results for ΔF values at baseline and after 
treatment. 
 
Paired Differences 
Sig. 
(2-
tailed) Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
0 ppm 
 
 
ΔF at 
baseline 
– 
ΔF after 
treatment 
 
2.210 3.977 0.795 0.568 3.852 0.010* 
500 ppm 5.951 3.809 0.747 4.412 7.489 0.000* 
1000 
ppm 
4.742 3.442 0.675 3.351 6.132 0.000* 
1450 
ppm 
5.957 4.113 0.822 4.259 7.655 0.000* 
2800 
ppm 
5.860 3.837 0.752 4.310 7.410 0.000* 
5000 
ppm 
5.460 3.777 0.740 3.934 6.986 0.000* 
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3.2.1.2 Difference in ΔF between all groups: 
The ΔF difference (change) was measured using the following formula:   
Difference in ΔF = ΔF after treatment - ΔF at baseline 
(Figure 43) shows the difference in ΔF in the six tested groups. In all groups the 
difference in ΔF was positive, meaning that there was decrease in ΔF (mean 
fluorescence loss) after treatment compared to that at baseline. The reduction in ΔF was 
almost identical in the 500, 1450, and  2800 ppm groups (5.951 ± 3.81) (5.957 ± 4.11) 
(5.860 ± 3.84) respectively. As for the 1000, and 5000 ppm groups, they were slightly 
lower and more similar with the former being at (4.742 ± 3.44) and the latter at (5.460 ± 
3.78). The lowest reduction in ΔF was found in the 0 ppm Group showing only (2.211 ± 
3.98) mean reduction (Table 31). 
 
Figure 43 Means of the difference in ΔF at baseline and after treatment of all 
groups. 
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Table 31 Descriptive statistics for the difference in ΔF at baseline and after 
treatment for all groups 
Group N Minimum Maximum Mean Median 
Std. 
Deviation 
0 ppm 25 -6.033 9.067 2.210 1.366 1.366 
500 ppm 26 -1.867 13.467 1.36667 1.36667 3.809290 
1000 ppm 26 -2.867 11.833 4.74231 4.43333 3.442771 
1450 ppm 25 -0.200 13.867 5.95733 4.50000 4.113151 
2800 ppm 26 -0.567 12.733 5.86026 4.88333 3.837036 
5000 ppm 26 -0.500 13.200 5.46026 4.68333 3.777666 
 
Determination of the normality of the data for Difference in ΔF: 
In order to check if the ΔF differences between the baseline and after treatment were 
normally distributed, data normality test was carried out. This included Shapiro-Wilk test 
and Kolmogorov-Smirnov test. p value was not statistically significant therefore data was 
considered to be normally distributed (p >0.05). 
The boxplot (Figure 44) of difference in ΔF at baseline and after treatment showed 
normal distribution of data in all groups. The boxplot also shows 0 ppm group having the 
lowest median value when compared to all other test groups. 
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Figure 44 Boxplot for the difference in ΔF at baseline and after treatment for all 
groups. 
 
One way ANOVA test (Table 32) was performed to assess if the difference in ΔF was 
statistically significant between the six groups. It showed that the mean difference in ΔF 
was statistically significant between the groups (p <0.05). 
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Table 32 One way ANOVA between groups for the difference in ∆F at baseline and 
after treatment. 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Between Groups 267.145 5 53.429 3.645 0.004* 
Within Groups 2169.647 148 14.660   
Total 2436.792 153    
 
In order to determine which groups were statistically significant different, pairwise 
comparisons were conducted using a Bonferroni test. The Bonferroni tests corrects for 
multiple testing. The results of the Bonferroni tests are shown in (Table 33)
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Table 33 Multiple comparisons of the difference in ∆F at baseline and after 
treatment between all test groups and control with Bonferroni correction. 
(I) 
Group 
(J) 
Group 
Mean Difference 
(I-J) 
Std. 
Error 
Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
0 ppm 
500 -3.740615* 1.072487 .010* -6.94048 -.54075 
1000 -2.531641 1.072487 .293 -5.73151 .66823 
1450 -3.746667* 1.082951 .011* -6.97775 -.51558 
2800 -3.649590* 1.072487 .013* -6.84946 -.44972 
5000 -3.249590* 1.072487 .043* -6.44946 -.04972 
500 ppm 
0 3.740615* 1.072487 .010* .54075 6.94048 
1000 1.208974 1.061920 1.000 -1.95937 4.37732 
1450 -.006051 1.072487 1.000 -3.20592 3.19382 
2800 .091026 1.061920 1.000 -3.07732 3.25937 
5000 .491026 1.061920 1.000 -2.67732 3.65937 
1000 
ppm 
0 2.531641 1.072487 .293 -.66823 5.73151 
500 -1.208974 1.061920 1.000 -4.37732 1.95937 
1450 -1.215026 1.072487 1.000 -4.41489 1.98484 
2800 -1.117949 1.061920 1.000 -4.28629 2.05039 
5000 -.717949 1.061920 1.000 -3.88629 2.45039 
1450 
ppm 
0 3.746667* 1.082951 .011* .51558 6.97775 
500 .006051 1.072487 1.000 -3.19382 3.20592 
1000 1.215026 1.072487 1.000 -1.98484 4.41489 
2800 .097077 1.072487 1.000 -3.10279 3.29695 
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5000 .497077 1.072487 1.000 -2.70279 3.69695 
2800 
ppm 
0 3.649590* 1.072487 .013* .44972 6.84946 
500 -.091026 1.061920 1.000 -3.25937 3.07732 
1000 1.117949 1.061920 1.000 -2.05039 4.28629 
1450 -.097077 1.072487 1.000 -3.29695 3.10279 
5000 .400000 1.061920 1.000 -2.76834 3.56834 
5000 
ppm 
0 3.249590* 1.072487 .043* .04972 6.44946 
500 -.491026 1.061920 1.000 -3.65937 2.67732 
1000 .717949 1.061920 1.000 -2.45039 3.88629 
1450 -.497077 1.072487 1.000 -3.69695 2.70279 
2800 -.400000 1.061920 1.000 -3.56834 2.76834 
*. The mean difference is significant at the 0.05 level. 
Table 33 (continued). 
It can be seen that the mean difference in ΔF of the 0 ppm (Control) toothpaste group is 
significantly lower than the mean difference in ΔF of all other test groups except for 1000 
ppm toothpaste. As for the significance between different concentrations of NaF fluoride 
toothpaste, there was no significance in any of the groups. 
3.2.1.3 The percentage change in ΔF at baseline and after treatment 
(%ΔF) was calculated using the following formula: 
(Difference in ΔF at baseline and after treatment / ΔF at baseline) × 100 
(Figure 45) shows the % change in ΔF values for all groups which was identical at 41.7% 
in both the 500 ppm and 5000 ppm groups. The lowest % change in ΔF values was 
found in the control 0 ppm group at 11.7%.  
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Figure 45 The % ΔF values for all groups. 
 
Determination of the normality of data for Percentage reduction in ΔF: 
In order to check if the percentage in reduction of ΔF was normally distributed, data 
normality test was carried out. This included Shapiro-Wilk test and Kolmogorov-Smirnov 
test. p value was statistically significant therefore data was not considered normally 
distributed (p<0.05). 
The Boxplot (Figure 46) of the percentage of reduction in ΔF showed one outlier in the 
500 ppm group and 2 outliers in the 1450 ppm group. All groups showed similar 
medians except for 0 ppm group which had a lower percentage reduction in ΔF. 
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Figure 46 Boxplot for the Percentage of reduction in ΔF for all groups. 
 
Non parametric Kruskal-Wallis test (Table 34) was performed to assess if the percentage 
reduction in ΔF was statistically significant between the five groups. It showed that the 
mean percentage reduction of ΔF was statistically significant between groups (p<0.05). 
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Table 34 Kruskal-Wallis Test results for the Percentage of reduction in ΔF. 
 Percentage of reduction in ΔF 
Chi-Square 13.421 
df 5 
Asymp. Sig. .020 
a. Kruskal Wallis Test 
b. Grouping Variable: Formulation 
 
In order to determine which groups were statistically significant different, pairwise 
comparison was performed (Figure 47). The test showed significant % reduction in ΔF 
for all test groups when compared to 0 ppm control group except for the 1000 ppm 
group which showed no significant difference. No other significant differences were 
found. 
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Figure 47 Pairwise comparison between percentages of reduction in ΔF between 
all Concentrations 
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3.2.1.4 Intra-examiner reproducibility for ΔF 
The intra-examiner reproducibility was tested using intra-class correlation coefficient. 24 
enamel slabs (15%) were randomly selected and re-analysed. The Intra-class 
Correlation Coefficient (Table 35) was found to be (0.99) which  represents excellent 
reproducibility. 
Table 35 Intra-class Correlation Coefficient for ΔF measurements. 
 
Intra-class 
Correlation 
95% Confidence 
Interval 
F Test with True Value 0 
Lower 
Bound 
Upper 
Bound 
Value df1 df2 Sig 
Single 
Measures 
.989 .978 .994 176.103 24 24 .000 
Average 
Measures 
.994 .989 .997 176.103 24 24 .000 
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3.2.2 ΔQ: ΔF times the Area. Percentage fluorescence loss with 
respect to the fluorescence of sound tissue times the area. 
Lesion volume 
Normality tests (Shapiro-Wilk test and Kolmogorov-Smirnov test) were done for the ΔQ 
values at baseline and showed that the data were normally distributed for all groups 
(Appendix 6). 
The boxplot (Figure 48) for the distribution of the ΔQ at the baseline showed similar 
distribution of medians between the groups. 5000 ppm group had one outlier. 
 
 
Figure 48 Boxplot for the distribution of the ΔQ values at baseline for all groups. 
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One way ANOVA test (Table 36) was performed to assess if there was any statistically 
significant difference in ΔQ at the baseline between the lesions assigned to the six 
groups. No statistically significant difference was found. 
Table 36 One way ANOVA results for ΔQ values at baseline. 
 Sum of Squares df Mean Square F Sig. 
Between 
Groups 
1.38E+9 5 2.76E+8 1.740 0.129 
Within Groups 2.3E+10 148 1.58E+8   
Total 2.5+10 153    
 
3.2.2.1 Difference in ΔQ within each group: 
The ΔQ mean values both at baseline and after treatment are shown in (Table 37).  It 
can be seen that there was an improvement in ΔQ values for all the groups in the study.
 
 
122 
 
Table 37 The mean values of ΔQ at baseline and after treatment for all groups. 
Group Mean ΔQ at 
baseline ± SD 
Mean ΔQ 
after 
treatment ± 
SD 
Mean Difference in ΔQ at 
baseline and after treatment ± 
SD 
0 ppm 26468.03 ± 
14321.27 
19435.37 ± 
8249.20 
7032.65 ± 13554.28 
500 ppm 20878.17 ± 
12330.29 
2515.14 ± 
4794.04 
18363.03 ± 13133.36 
1000 ppm 20155.91 ± 
13009.99 
2411.55 ± 
3877.49 
17744.36 ± 14014.81 
1450 ppm 23800.89 ± 
11342.64 
852.73 ± 
957.35 
22948.16 ± 10979.76 
2800 ppm 26162.40 ± 
13975.89 
3848.77 ± 
4683.02 
22313.63 ± 13585.87 
5000 ppm 18643.92 ± 
10059.03 
2278.05 ± 
3205.92 
16365.87 ± 9117.05 
 
(Figure 49) shows the change in the mean of ΔQ at baseline and after treatment with the 
standard deviation for all groups. 
 
Figure 49 ΔQ mean values at baseline and after treatment for all groups. 
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To assess whether the change in ΔQ at baseline and after treatment was significantly 
different within the same group, paired T-Test was carried out and the results (Table 38) 
showed that there was a statistically significant improvement in the ΔQ values after 
treatment compared with that at baseline in all treatment groups (p<0.05). 
Table 38 Paired sampled T-Test results for ΔQ values at baseline and after 
treatment. 
 
Paired Differences 
Sig. 
(2-
tailed
) 
Mean 
Std. 
Deviatio
n 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
0 ppm 
 
 
ΔQ at 
baseli
ne 
– 
ΔQ 
after 
treatm
ent 
 
7032.65
3 
13554.2
8 
2710.85
6 
0.568 3.852 
0.016
* 
500 
ppm 
18363.0
3 
13133.3
6 
2575.66
4 
13058.3
5 
23667.7
0 
0.000
* 
1000 
ppm 
17744.3
6 
14014.8
1 
2748.53
0 
3.351 6.132 
0.000
* 
1450 
ppm 
22948.1
6 
10979.7
6 
2195.95
3 
18415.9
4 
27480.3
8 
0.000
* 
2800 
ppm 
22313.6
3 
13585.8
7 
2664.40
8 
16826.1
8 
27801.0
8 
0.000
* 
5000 
ppm 
16365.8
7 
9117.04
8 
1788 
12683.4
2 
20048.3
3 
0.000
* 
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3.2.2.2 Difference in ΔQ between groups 
The ΔQ difference (change) was measured using the following formula:   
Difference in ΔQ = ΔQ after treatment - ΔQ at baseline 
(Figure 50) shows the difference in ΔQ in the six tested groups. In all groups the 
difference in ΔQ was positive, meaning that there was decrease in ΔQ after treatment 
compared to that at baseline. The highest reduction  in ΔQ was in the 1450 ppm F 
toothpaste group with a mean difference of (22948.16 ± 10979.76) , while the lowest 
reduction was in the 0 ppm F group with only (7032.65 ± 13554.28) mean difference. 
The rest of the groups were roughly similar in range. 
 
Figure 50 Means of the difference in ΔQ at baseline and after treatment of all 
groups. 
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Table 39 Descriptive statistics for the difference in ΔQ at baseline and after 
treatment for all groups. 
Group N Minimum Maximum Mean Median 
Std. 
Deviation 
0 ppm 25 
-
10204.33
3 
37578.66
7 
7032.6533
3 
4418.0000
0 
13554.28076
3 
500 
ppm 
26 .000 
48433.33
3 
18363.025
64 
18866.333
33 
13133.36014
6 
1000 
ppm 
26 
-
10443.66
7 
52795.66
7 
17744.358
97 
14795.000
00 
14014.80638
8 
1450 
ppm 
25 7813.667 
44060.66
7 
22948.160
00 
20896.333
33 
10979.76346
2 
2800 
ppm 
26 1127.667 
47357.00
0 
22313.628
21 
21675.833
33 
13585.86618
8 
5000 
ppm 
26 4816.333 
38843.00
0 
16365.871
79 
14379.166
67 
9117.048450 
 
Determination of the normality of the data 
 Shapiro-Wilk test and Kolmogorov-Smirnov test was carried out to check if the 
difference in ΔQ at baseline and after treatment was normally distributed. The data was 
considered normally distributed, as there was no statistical significance. 
The boxplot (Figure 51) of difference in ΔQ at baseline and after treatment shows 0 ppm 
F group having the lowest median value with all other groups having a similar range. 
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Figure 51 Boxplot for the difference in ΔQ at baseline and after treatment for all 
groups. 
 
One way ANOVA test (Table 40) was performed to assess if the difference in ΔQ was 
statistically significant between the five groups. It showed that the mean difference in ΔQ 
was statistically significant between the groups (p <0.001). 
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Table 40 One way ANOVA between groups for the difference in ∆Q at baseline and 
after treatment. 
 Sum of Squares df Mean Square F Sig. 
Between Groups 4137994560.022 5 827598912.004 5.276 0.000* 
Within Groups 23217476567.744 148 156874841.674 
  
Total 27355471127.766 153 
   
 
In order to determine which groups were statistically significant different, pairwise 
comparisons were conducted using Bonferroni test. The Bonferroni tests corrects for 
multiple testing. The results of the Bonferroni tests are shown in (Table 41).  
The results show that there was a statistically significant difference in ΔQ of all groups 
except 5000 ppm F when compared to 0 ppm F (Control) group. No other statistical 
significance was found between groups.
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Table 41 Multiple comparisons of the difference in ∆Q at baseline and after 
treatment between all test groups and control. 
(I) 
Group 
(J) 
Group 
Mean 
Difference (I-J) 
Std. Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
0 ppm 
500 -11330.372308* 3508.367344 .023* -21797.92485 -862.81977 
1000 -10711.705641* 3508.367344 .040* -21179.25818 -244.15310 
1450 -15915.506667* 3542.596129 .000* -26485.18409 -5345.82925 
2800 -15280.974872* 3508.367344 .000* -25748.52741 -4813.42233 
5000 -9333.218462 3508.367344 .130 -19800.77100 1134.33408 
500 
ppm 
0 11330.372308* 3508.367344 .023* 862.81977 21797.92485 
1000 618.666667 3473.801306 1.000 -9745.75476 10983.08809 
1450 -4585.134359 3508.367344 1.000 -15052.68690 5882.41818 
2800 -3950.602564 3473.801306 1.000 -14315.02399 6413.81886 
5000 1997.153846 3473.801306 1.000 -8367.26758 12361.57527 
1000 
ppm 
0 10711.705641* 3508.367344 .040* 244.15310 21179.25818 
500 -618.666667 3473.801306 1.000 -10983.08809 9745.75476 
1450 -5203.801026 3508.367344 1.000 -15671.35356 5263.75151 
2800 -4569.269231 3473.801306 1.000 -14933.69066 5795.15220 
5000 1378.487179 3473.801306 1.000 -8985.93425 11742.90861 
1450 
ppm 
0 15915.506667* 3542.596129 .000* 5345.82925 26485.18409 
500 4585.134359 3508.367344 1.000 -5882.41818 15052.68690 
1000 5203.801026 3508.367344 1.000 -5263.75151 15671.35356 
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2800 634.531795 3508.367344 1.000 -9833.02074 11102.08433 
5000 6582.288205 3508.367344 .939 -3885.26433 17049.84074 
2800 
ppm 
0 15280.974872* 3508.367344 .000* 4813.42233 25748.52741 
500 3950.602564 3473.801306 1.000 -6413.81886 14315.02399 
1000 4569.269231 3473.801306 1.000 -5795.15220 14933.69066 
1450 -634.531795 3508.367344 1.000 -11102.08433 9833.02074 
5000 5947.756410 3473.801306 1.000 -4416.66502 16312.17784 
5000 
ppm 
0 9333.218462 3508.367344 .130 -1134.33408 19800.77100 
500 -1997.153846 3473.801306 1.000 -12361.57527 8367.26758 
1000 -1378.487179 3473.801306 1.000 -11742.90861 8985.93425 
1450 -6582.288205 3508.367344 .939 -17049.84074 3885.26433 
2800 -5947.756410 3473.801306 1.000 -16312.17784 4416.66502 
*. The mean difference is significant at the 0.05 level. 
Table 41 (continued). 
 
3.2.2.3 The percentage of the changes in ΔQ at baseline and after 
treatment (%ΔQ) was calculated using the following formula: 
(Difference in ΔQ at baseline and after treatment / ΔQ at baseline) × 100 
(Figure 52) shows the % ΔQ change values for all groups with 1450 ppm F group having 
96.4% reduction in ΔQ, while 0 ppm F group had on 3.1% reduction. All other groups 
were similar in percentage range. 
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Figure 52 The %ΔQ values for all groups. 
 
Determination of the normality of data for Percentage reduction in ΔQ: 
In order to check if the percentage in reduction of ΔQ was normally distributed, data 
normality test was carried out. This included Shapiro-Wilk test and Kolmogorov-Smirnov 
test. p value was statistically significant therefore data was not considered normally 
distributed (p<0.001). 
The Boxplot (Figure 53) of the percentage of reduction in ΔQ for all groups shows that 
the data is not normally distributed, and that there are several outliers in all groups, most 
of these outliers being in the 500, and 1000 ppm F groups. The median decrease in 
percentage value is lowest in the 0 ppm group while all other groups have similar 
median values. 
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Figure 53 Boxplot for the Percentage of reduction in ΔQ for all groups. 
 
Non parametric Kruskal-Wallis test (Table 42) was performed to assess if the percentage 
reduction in ΔQ was statistically significant between the six groups. It showed that the 
mean percentage reduction of ΔQ was statistically significant between groups (p<0.001). 
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Table 42 Kruskal-Wallis Test results for the Percentage of reduction in ΔQ. 
 Percentage of reduction in ΔQ 
Chi-Square 60.983 
df 5 
Asymp. Sig. 0.000 
a. Kruskal Wallis Test 
b. Grouping Variable: Formulation 
 
In order to determine which groups were statistically significant different, pairwise 
comparison was performed (Figure 54). The test shows that there was significant 
difference in percentage reduction of ΔQ found in all groups when compared to 0 ppm F 
toothpaste (Control) group. There was no statistical significance between test groups. 
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Figure 54 Pairwise comparison between percentages of reduction in ΔQ between 
all concentrations. 
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3.2.2.4 Intra-examiner reproducibility for ΔQ 
The intra-examiner reproducibility was tested using intra-class correlation coefficient. 24 
enamel slabs (15%) were randomly selected and re-analysed. The Intra-class 
Correlation Coefficient (Table 43) was found to be (0.99) which  represents excellent 
reproducibility. 
Table 43 Intra-class Correlation Coefficient for ΔQ measurements. 
 
Intra-class 
Correlation 
95% Confidence 
Interval 
F Test with True Value 0 
Lower 
Bound 
Upper 
Bound 
Value df1 df2 Sig 
Single 
Measures 
.989 .978 .994 174.246 24 24 .000 
Average 
Measures 
.994 .989 .997 174.246 24 24 .000 
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3.2.3 Area of the white spot lesion: 
The values of area of white spot lesion at baseline for all groups were checked to see if 
there was a difference between the groups. The normality tests (Shapiro-Wilk test and 
Kolmogorov-Smirnov test) were carried out to check the normality of the data. The data 
were considered normally distributed if the p values from these tests were not statistically 
significant (p >0.05).  p values for  all groups except for 5000 ppm F group were not 
statistically significant therefore data was considered to be normally distributed 
(Appendix 7). 
The boxplot (Figure 55) for the distribution of the area of white spot lesion at the baseline 
showed variation of median values between groups with one outlier in the 2800 ppm F 
group. 
 
Figure 55 Boxplot for the distribution of the Area values at baseline for all groups. 
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One way ANOVA test (Table 44) was performed to assess if there was any statistically 
significant difference in the area values at the baseline between the lesions assigned to 
the six groups. No statistically significant difference was found. 
Table 44 One way ANOVA results for Area values at baseline. 
 Sum of Squares df Mean Square F Sig. 
Between Groups 5074366 5 1014873 2.036 0.077 
Within Groups 7.38E+7 148 498485.4   
Total 7.89E+7 153    
 
3.2.3.1 Difference in lesion area within each group 
The lesion area mean values both at baseline and after treatment are shown in (Table 
45). It can be seen that there was a decrease in the lesion area for all groups in the 
study.
 
 
137 
 
Table 45 The mean values of area at baseline and after treatment for all groups. 
Group 
Mean area at 
baseline ± SD 
Mean area 
after 
treatment ± 
SD 
Mean Difference in area at 
baseline and after treatment ± 
SD 
0 ppm 
1869.25 ± 
714.61 
1683.2 ± 
576.10 
-186.05 ± 502.13 
500 ppm 
1515.21 ± 
757.09 
208.27 ± 
341.80 
-1314.94 ± 796.84 
1000 ppm 
1487.82 ± 
772.72 
270.09 ± 
392.63 
-1217.73 ± 907.03 
1450 ppm 
1778.69 ± 
575.41 
98.99 ± 
104.45 
-1679.70 ± 548.75 
2800 ppm 
1869.40 ± 
792.07 
437.12 ± 
493.30 
-1432.28 ± 874.73 
5000 ppm 
1447.72 ± 
587.61 
257.86 ± 
344.89 
-1189.85 ± 500.73 
 
(Figure 56) shows the change in the mean of area at baseline and after treatment with 
the standard deviation for all groups. 
 
Figure 56 Lesion area at baseline and after treatment for all groups. 
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To assess whether the change in the area at baseline and after treatment was 
significantly different within the same group, paired T-Test was used. 
The paired T-Test results shown in (Table 46) showed that there was a statistically 
significant improvement in the lesion area values after treatment compared with that at 
baseline, for  all toothpaste test groups (p <0.001) except the 0 ppm F (Control) 
toothpaste (p>0.05). 
Table 46 Paired sampled T test results for the lesion area values at baseline and 
after treatment for all groups. 
 
Paired Differences 
Sig. (2-
tailed) 
Mean 
Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
0 ppm 
 
 
Area at 
baseline 
– 
Area 
after 
treatment 
 
-
186.053 
502.1382 100.42 
-
393.326 
21.219 0.076 
500 ppm 
-
1314.95 
796.84 156.27 
-
1636.80 
-993.09 0.000* 
1000 ppm 
-
1217.73 
907.04 177.88 
-
1584.09 
-851.36 0.000* 
1450 ppm 
-
1679.71 
548.75 109.75 
-
1906.22 
-
1453.19 
0.000* 
2800 ppm 
-
1432.28 
874.73 171.55 
-
1785.60 
-
1078.97 
0.000* 
5000 ppm 
-
1189.86 
500.73 98.20 
-
1392.11 
-
987.606 
0.000* 
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3.2.3.2 Difference in lesion area between groups 
The lesion area difference (change) was measured using the following formula:   
Difference in lesion area= lesion area after treatment – lesion area at baseline 
(Figure 57) shows the difference in the lesion area for the six tested groups. In all test 
groups, the mean difference was negative indicating a decrease in area of the lesion 
after treatment compared to that at baseline. 
The highest reduction in area size was found in the 1450 ppm F toothpaste group -
1679.707 ± 548.76. While The lowest reduction in lesion size was in the 0 ppm F 
(control) group -186.053 ± 502.14. All other test groups were similar in range of 
difference in area. 
 
Figure 57 Means of the difference in the lesion area at baseline and after treatment 
of all tested groups. 
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Table 47 Descriptive statistics for the difference in Lesion Area at baseline and 
after treatment for all groups. 
Group N Minimum Maximum Mean Median 
Std. 
Deviation 
0 ppm 25 -1312.667 600.667 -186.05333 -130.33333 502.138212 
500 ppm 26 -2544.333 13.333 
-
1314.94872 
-
1344.33333 
796.849935 
1000 ppm 26 -2688.000 1051.333 
-
1217.73077 
-
1140.00000 
907.039982 
1450 ppm 25 -2804.333 269.667 
-
1679.70667 
-
1751.66667 
548.757210 
2800 ppm 26 -3366.667 202.333 
-
1432.28205 
-
1220.50000 
874.737912 
5000 ppm 26 -2297.000 -419.667 
-
1189.85897 
-
1155.50000 
500.738088 
 
Determination of the normality of lesion area difference at baseline and after 
treatment data: 
In order to check if the differences in the lesion area at baseline and after treatment were 
normally distributed, data normality test was carried out. This included Shapiro-Wilk test 
and Kolmogorov-Smirnov test. The data was considered normally distributed as there 
was no significance. 
The boxplot (Figure 58) of difference in the lesion area at baseline and after treatment 
shows similar range of median values for all test groups except 0 ppm F Control group, 
which had a much lower median value. The data appeared normally distributed and no 
outliers were detected. 
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Figure 58 Boxplot for the difference in the lesion Area at baseline and after 
treatment for all groups. 
 
One way ANOVA test (Table 48) was performed to assess if the difference in area was 
statistically significant between the five groups. It showed that the mean difference in 
area was statistically significant between the groups (p <0.001). 
Table 48 One way ANOVA between groups for the difference in Area at baseline 
and after treatment. 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Between Groups 33101583.243 5 6620316.649 13.043 .000 
Within Groups 75118564.128 148 507557.866 
  
Total 108220147.371 153 
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In order to determine which groups were statistically significant different, pairwise 
comparisons were conducted using Bonferroni test. The Bonferroni tests corrects for 
multiple testing. The results of the Bonferroni tests are shown in (Table 49). The results 
revealed that there was significant difference in area of white spot lesions of all test 
groups when compared to 0 ppm F (control) group. No other significant differences were 
found between the test groups. 
Table 49 Multiple comparisons of the difference in Area at baseline and after 
treatment between all test groups and control. 
(I) 
Group 
(J) 
Group 
Mean 
Difference (I-J) 
Std. Error Sig. 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
0 ppm 
500 1128.895385* 199.558941 .000* 533.49203 1724.29874 
1000 1031.677436* 199.558941 .000* 436.27408 1627.08079 
1450 1493.653333* 201.505904 .000* 892.44102 2094.86564 
2800 1246.228718* 199.558941 .000* 650.82536 1841.63208 
5000 1003.805641* 199.558941 .000* 408.40228 1599.20900 
500 
ppm 
0 -1128.895385* 199.558941 .000* -1724.29874 -533.49203 
1000 -97.217949 197.592795 1.000 -686.75512 492.31922 
1450 364.757949 199.558941 1.000 -230.64541 960.16131 
2800 117.333333 197.592795 1.000 -472.20384 706.87051 
5000 -125.089744 197.592795 1.000 -714.62692 464.44743 
1000 
ppm 
0 -1031.677436* 199.558941 .000* -1627.08079 -436.27408 
500 97.217949 197.592795 1.000 -492.31922 686.75512 
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1450 461.975897 199.558941 .330 -133.42746 1057.37926 
2800 214.551282 197.592795 1.000 -374.98589 804.08845 
5000 -27.871795 197.592795 1.000 -617.40897 561.66538 
1450 
ppm 
0 -1493.653333* 201.505904 .000* -2094.86564 -892.44102 
500 -364.757949 199.558941 1.000 -960.16131 230.64541 
1000 -461.975897 199.558941 .330 -1057.37926 133.42746 
2800 -247.424615 199.558941 1.000 -842.82797 347.97874 
5000 -489.847692 199.558941 .229 -1085.25105 105.55567 
2800 
ppm 
0 -1246.228718* 199.558941 .000* -1841.63208 -650.82536 
500 -117.333333 197.592795 1.000 -706.87051 472.20384 
1000 -214.551282 197.592795 1.000 -804.08845 374.98589 
1450 247.424615 199.558941 1.000 -347.97874 842.82797 
5000 -242.423077 197.592795 1.000 -831.96025 347.11410 
5000 
ppm 
0 -1003.805641* 199.558941 .000* -1599.20900 -408.40228 
500 125.089744 197.592795 1.000 -464.44743 714.62692 
1000 27.871795 197.592795 1.000 -561.66538 617.40897 
1450 489.847692 199.558941 .229 -105.55567 1085.25105 
2800 242.423077 197.592795 1.000 -347.11410 831.96025 
*. The mean difference is significant at the 0.05 level. 
Table 49 (continued). 
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3.2.3.3 The percentage change in lesion area at baseline and after 
treatment (% Area) was calculated using the following formula: 
(Difference in area at baseline and after treatment / area at baseline) × 100 
(Figure 59) shows the % Area values for all groups, with 1000 ppm F group having the 
highest % reduction in area of lesion 94.4%, followed by 5000, and 500 ppm F Groups 
at 84.5% and 82.5% respectively. The lowest % reduction in area was located in the 0 
ppm F (control) Group at 0.1%. 
 
Figure 59 The % Area values for all groups. 
 
Determination of the normality of data for Area: 
In order to check if the percentage in reduction of area was normally distributed, data 
normality test was carried out. This included Shapiro-Wilk test and Kolmogorov-Smirnov 
test. P value was statistically significant therefore data was not considered normally 
distributed (p<0.001). 
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The Boxplot (Figure 60) of the percentage of reduction in Area for all groups shows that 
the data is not normally distributed, and that there are several outliers in all groups. 
 
Figure 60 Boxplot for the Percentage of reduction in Area for all groups. 
 
Non parametric Kruskal-Wallis test (Table 50) was performed to assess if the percentage 
reduction in area was statistically significant between the six groups. It showed that the 
mean percentage reduction of area was statistically significant between groups 
(p<0.001). 
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Table 50 Kruskal-Wallis Test results for the Percentage of reduction in Area. 
 Percentage of reduction in Area 
Chi-Square 64.444 
df 5 
Asymp. Sig. 0.000 
a. Kruskal Wallis Test 
b. Grouping Variable: Formulation 
 
In order to determine which groups were statistically significant different, pairwise 
comparison was performed (Figure 61). The results revealed a significant difference in 
mean percentage reduction of white spot lesion area of all test groups when compared to 
0 ppm F (control) group. No other statistical significance was evident. 
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Figure 61 Pairwise comparison between percentages of reduction in Area between 
all formulations. 
 
 
148 
 
 
3.2.3.4 Intra-examiner reproducibility for Area of the white spot lesion 
The intra-examiner reproducibility was tested using intra-class correlation coefficient. 24 
enamel slabs (15%) were randomly selected and re-analysed. The Intra-class 
Correlation Coefficient (Table 51) was found to be (0.99) which  represents excellent 
reproducibility. 
Table 51 Intra-class Correlation Coefficient for Area measurements. 
 
Intra-class 
Correlation 
95% Confidence 
Interval 
F Test with True Value 0 
Lower 
Bound 
Upper 
Bound 
Value df1 df2 Sig 
Single 
Measures 
.992 .983 .996 230.060 24 24 .000 
Average 
Measures 
.996 .992 .998 230.060 24 24 .000 
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3.2.4 Summary of the results for all three parameters for phase B: 
The ΔF results: the results showed that there were statistically significant improvement 
in the ΔF values between the baseline and after treatment for all groups. The reduction 
in ΔF was highest, and almost identical in the 500, 1450, and  2800 ppm F groups, 
followed by 5000 ppm, 1000 ppm and the lowest improvement was seen in the 0 ppm F 
group. 
When comparing the groups against each other, it can be seen that the mean difference 
in ΔF of the 0 ppm F (Control) toothpaste group is significantly lower than the mean 
difference in ΔF of all other test groups except for 1000 ppm F toothpaste. As for the 
significance between different concentrations of NaF fluoride toothpaste, there was no 
significance in any of the groups. 
The ΔQ results: A statistically significant improvement in the ΔQ values between the 
baseline and after treatment was found in all groups. The highest improvement was 
achieved by the 1450  ppm F group followed by 2800 ppm F and the least improvement 
was seen in the 0 ppm F group (control). 
When comparing the groups against each other, the difference in ΔQ at baseline and 
after treatment in all test groups was statistically significant higher than that for the 0 
ppm F group except for the 5000 ppm F group. No other statistical significance was 
found between groups. 
For the lesion area results: A significant reduction in the area of the white spot lesion 
was seen in all groups except for the 0 ppm F group. The highest reduction was found in 
the 1450 ppm F group followed by the 2800, 500, 1000, 5000 ppm F groups In 
descending order. 
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When comparing the groups against each other, the difference in the lesion area at 
baseline and after treatment was statistically significant for the test groups compared 
with the 0 ppm F group. No significant difference was found between the test groups.
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Chapter 4 DISCUSSION 
Multiple in vitro, in situ, and in vivo studies investigating the effects of different fluoride 
formulations or fluoride concentrations on enamel subsurface lesion remineralisation are 
available. However the vast majority of these studies only compare one or two 
formulations/ concentrations against fluoride-free or placebo toothpaste.  
Furthermore, pH cycling in vitro studies published in the literature are usually of a limited 
time period and usually extend for no longer than 14 days, during which enamel is left in 
demineralising/ remineralising solutions of high concentrations for prolonged periods of 
time and at high concentrations unlike the conditions of the oral environment. 
Therefore the current in vitro study aimed to investigate the remineralising potential of 
toothpastes with different Fluoride (F) formulations: amine fluoride (AmF), sodium 
monofluorophosphate (MFP), sodium fluoride (NaF), and stannous fluoride (SnF) on 
artificial subsurface caries lesions. 
Another aim was to investigate the remineralising potential of toothpastes containing 
sodium fluoride (NaF) formulation at different concentrations of fluoride (500, 1000, 
1450, 2800 and 5000 ppm F) on artificial subsurface caries lesions in vitro. 
4.1 In vitro model 
This study used an in vitro model to study enamel remineralisation using different 
fluoride formulations and concentrations. In in vitro studies, the clinical efficacy of  
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fluoride toothpastes are estimated using different models that attempt to simulate the 
conditions of the oral cavity, and the process of caries formation. 
The caries process is a continuum of demineralisation and remineralisation which has 
been referred to as the ionic seesaw. Therefore pH cycling models appear to be the 
most suitable for investigating the effect of anti-caries fluoride toothpastes (Tenuta and 
Cury, 2013). In vitro pH cycling models mimic the dynamics of mineral loss or gain 
involved in the caries process, and the have been used widely to evaluate the efficacy of 
fluoridated toothpastes on caries control (Buzalaf et al., 2010). 
Stookey et al. (2011) published a study that looked at the robustness, and the ability to 
predict the anti-caries performance of fluoride containing products by using the in vitro 
pH cycling model. He compared data from three independent laboratories and concluded 
that the in vitro pH cycling model: 
1. Was capable of measuring the dose response from 0-1100 ppm F. 
2. The model was able to statistically separate positive from negative control. 
3. Dentifrice formulations proven to be clinically effective against caries, performed 
in this model at a level that was not statistically less effective than the positive 
control. 
4. This model was able to statistically differentiate between a product with 
attenuated fluoride activity (product formulated with the same level of fluoride as 
the positive control in addition to an ingredient known to compromise fluoride 
effectiveness) from the positive control. 
For the reasons mentioned above, in vitro pH cycling continues to be an effective tool in 
evaluating the efficacy of fluoridated toothpastes on caries control. 
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In-spite of all the advantages in vitro studies provide, the main limitation continues to be 
the inability to simulate the complex biological processes associated with caries 
(Xuedong, 2016), and the inability to replicate and reproduce precisely the conditions of 
the oral environment (Higham et al., 2005). 
4.2 Study design 
This was a two phase in vitro study design to investigate the remineralisation of the 
enamel subsurface lesions under pH cycling conditions using different fluoride 
formulations (phase A), and different NaF concentrations (phase B). 
Five fluoride toothpaste formulations were investigated in phase A including the negative 
control (F-Free, NaF, SnF, MFP, and AmF). 
Six NaF toothpaste concentrations were investigated in phase B including the negative 
control (0 ppm, 500 ppm, 1000 ppm, 1450 ppm, 2800 ppm, 5000 ppm F). 
A randomised, single-blinded design was used to prevent the introduction of bias in the 
study. 
4.3 Bovine teeth 
Human teeth can be regarded as the most appropriate source of dental substrate to be 
used in pH cycling models in terms of clinical relevance. However, their composition is 
variable, due to genetic influences, environmental conditions and age. These differences 
lead to large variations in their response under acidic challenges (Buzalaf et al., 2010). 
Furthermore, sources of human teeth are becoming more and more limited and there is 
a significant increase in difficulty of obtaining human teeth for research purposes 
(Stookey et al., 2011). 
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Bovine teeth are easier to obtain, have a more uniform composition when compared to 
human teeth, and have been generally demonstrated to perform similarly to human teeth 
(Tanaka et al., 2008, Costa et al., 2015). For this reason, bovine enamel can offer a 
suitable alternative to human enamel for in vitro pH cycling models, and they provide a 
less variable response to both cariogenic challenge and anti-caries treatment such as 
fluoridated dentifrices (Mellberg, 1992, ten Cate and Mundorff-Shrestha, 1995). 
However, due to slight differences between bovine and human enamel in terms of 
mineral content and porosity (Edmunds et al., 1988), Stookey et al. (2011) found that 
slight adjustment and increase of demineralisation pH was necessary to achieve similar 
results. Although bovine enamel is more porous than human enamel, which leads to 
faster demineralization and remineralization, these differences result in quantitative and 
not qualitative differences in behaviour (Buzalaf et al., 2010). 
Artificial caries lesions produced from bovine teeth, have a mineral distribution and 
structure that resembles lesions produced from human teeth for both enamel and 
dentine (Featherstone and Mellberg, 1981, Mellberg, 1992). 
Furthermore, the use of bovine teeth overcomes many disadvantages and obstacles laid 
down by the use of human teeth including (Yassen et al., 2011): 
 Difficulties in obtaining a large quantity of human teeth with good quality, as most 
extracted teeth are severely carious or broken down. 
 Difficulty in controlling the source and age of human teeth which may lead to 
large variations in outcome measures. 
 Relatively small curved surface area of human teeth may also be a limitation to 
specific tests requiring flat surfaces of uniform thickness. 
 Awareness of infection hazards and ethical issues has increased rendering it 
even more difficult to obtain a sufficient number of sound extracted human teeth. 
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4.4 Enamel slabs preparation and storage 
The buccal section of the bovine teeth was used in the present study to allow a more 
uniform thickness of enamel as well as more flat surfaces. The enamel slabs were stored 
in distilled water and 0.1% thymol (Sigma Aldrich) with the aim of inhibition of the 
bacterial growth and prevention of enamel slabs dehydration. The antimicrobial 
properties of thymol were proven through its ability to perforate cell membranes, and 
subsequently destroy the pathogens that may be present on the teeth (Shapiro and 
Guggenheim, 1995). At the same time thymol has no detrimental effect on enamel but a 
few studies showed that it can affect dentine permeability (Preston et al., 2007). 
The enamel and dentine thickness were found to influence the fluorescence, however; 
this confounding factor could not be absolutely standardised in the present study. Since 
only profound differences in the total thickness of the dental tissue was found to 
influence the caries assessment with the QLF (Ando et al., 2003), the impact of this 
factor is believed to be minimal on the results of the current study. 
4.5 Artificial caries lesions 
In the current study acidified hydroxyethyl cellulose gel was used to create a sub-surface 
caries-like lesion. The enamel slabs were immersed in the acidified gel for 10 days in 
order to produce enamel lesion with ∆F of similar range. 
Acidified hydroxyethyl cellulose gel, has been shown to be easy to use and creates 
lesions with consistent depths of demineralisation. Lesions created with this gel have 
also demonstrated more rigidity when compared with lesions produced by acetic acid 
buffer (Issa, 2004). 
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Lesions produced by acid buffer solutions have been shown to produce larger and 
deeper lesions than acidified gels (including Acidified hydroxyethyl cellulose gel). This 
can be explained by the rapid diffusion rate of acid buffer solutions which does not allow 
re-precipitation of minerals and therefore does not allow formation of an intact surface 
layer over the lesion (produces an erosion-like lesion). Acidified gels on the other hand 
create more controlled demineralisation process, and allow re-precipitation of dissolved 
mineral ions to create an intact surface layer of the lesion that mimics the caries process 
(Amaechi et al., 1998). 
4.6 pH cycling 
The origin of the modern pH cycling models was produced by (ten Cate and Duijsters, 
1982). In vitro pH cycling models mimic the dynamics of mineral loss or gain involved in 
the caries process, and the have been used widely to evaluate the efficacy of fluoridated 
toothpastes on caries control (Buzalaf et al., 2010). pH cycling in vitro studies published 
in the literature are usually of a limited time period and usually extend for no longer than 
14 days, during which enamel is left in demineralising/ remineralising solutions of high 
concentrations for prolonged periods of time and at high concentrations unlike the 
conditions of the oral environment. However in the current study, a 28 day period of pH 
cycling was implemented in order to allow sufficient time to produce changes in the pre-
demineralised enamel slabs. 
In the current study, enamel slabs were exposed to 5 acidic challenges per day in a 
demineralising solution. The enamel slabs were initially dipped in toothpaste slurry for 5 
minutes, then rinsed with distilled water for 1 minute and placed in day time artificial 
saliva. The enamel slabs were exposed to the first demineralisation challenge by dipping 
in acetic acid solution (pH 4.8) for 5 minutes, then rinsed with distilled water for 1 minute 
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and placed in day time artificial saliva. This process was repeated until the enamel slabs 
were subjected to 5 demineralisation challenges, which represent the acid in the 
cariogenic challenge. After the last cycle the enamel slabs were dipped in toothpaste 
slurry for 5 minutes. Enamel slabs were then placed in night time artificial saliva. 
The day time saliva was supersaturated with calcium and phosphate in order to allow 
remineralisation of enamel slabs during the day and it was used in between the 
demineralisation challenges for 60 minutes. On the other hand, the night time saliva was 
a saturated solution and it was used overnight to maintain the enamel condition without 
providing any mineral exchanges. 
The pH cycling protocol used for the current study was developed at the University of 
Leeds and  has been used in  previous caries studies at the Leeds Dental Institute-
Paediatric Dentistry Department. 
4.7 Quantitative Light-Induced Fluorescence (QLF) 
QLF is a system based on the measurement of fluorescence loss following enamel 
demineralisation. This method has been employed in pH-cycling experiments and has 
shown to be efficient at measuring the remineralisation of enamel subsurface lesions 
(Gomez et al., 2014). 
In the current study, QLF has been used to measure enamel demineralisation at 
baseline (after acid gel demineralisation for 10 days), and enamel lesion remineralisation 
following treatment with experimental toothpastes. QLF readings in the present study 
showed excellent reproducibility as intra-class correlation coefficients (ICCs) for inter-
examiner reliability for the image analysis was found to be (0.99). These results are in 
line with previous studies (Hafstrom-Bjorkman et al., 1992, Emami et al., 1996, Al-
Khateeb et al., 1997b, Tranaeus et al., 2002). 
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Pretty et al. (2002b), looked at the intra- (0.93) and inter-examiner reliability (0.96) of 
QLF analysis. The authors concluded that the analysis stage of QLF is reliable between 
examiners and within multiple attempts by the same examiner, when analysing in vitro 
lesions. 
Image capture technique was standardised, and the environment controlled for all 
enamel slabs in order to reduce the chances of bias. To ensure that images of the 
enamel slabs were always captured in the same camera positions and from the same 
angles, the camera was attached to a stand in the same position for all the images. The 
QLF camera was fixed at a position that provided optimum illumination of the enamel 
block surface.  The camera specimen distance was standardised thereby controlling 
specimen stability, light intensity, and magnification. 
To further reduce the risk of bias, the investigator was trained by the manufacturer and 
was familiar with the QLF software prior to study commencement. 
4.8 Quantitative Light-Induced Fluorescence (QLF) parameters  
As mentioned before, QLF produces three parameters that include; the ΔF which 
represents the percentage fluorescence loss and related to lesion depth, the surface 
area of the lesion as well as ΔQ which is the ΔF times the area and represent the lesion 
volume. All these values were calculated in this study; however, the ΔQ value was 
considered as the main indicator for the mineral loss and the lesion progression or 
regression in the present study. Since it was indicated that the lesion area may increases 
or decreases while the ΔF value maintained the same or alternatively the lesion area 
may be maintained despite the increase or decrease in ΔF value (Ando et al., 2004). For 
this reason the independent evaluation for these two values may not give a good 
evaluation of the lesions progression or regression. 
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4.9 Remineralising potential of toothpastes with different 
Fluoride (F) formulations on artificial subsurface caries 
lesions 
Phase A of the current study investigated the remineralising potential of toothpastes with  
different Fluoride (F) formulations: amine fluoride (AmF), sodium monofluorophosphate 
(MFP), sodium fluoride (NaF), and stannous fluoride (SnF) on artificial subsurface caries 
lesions  in vitro. Non-fluoride toothpaste was used as negative control. 
The study results demonstrated that in all QLF parameters (ΔF, ΔQ and lesion area) 
statistically significant remineralisation between baseline and after treatment was found 
in Naf, SnF and MFP toothpaste groups, but there was no such significance in the AmF 
and F Free groups. The highest remineralisation was achieved by the NaF  group 
followed by the SnF and finally the MFP group. 
When comparing the groups against each other, the difference in remineralisation at 
baseline and after treatment was statistically significantly higher in the NaF group when 
compared to AmF and F Free toothpaste groups only. Remineralisation in SnF group 
was significantly higher than AmF group only. No other statistical significance could be 
found. 
The reason behind the poor performance of AmF could possibly be due to the fact that 
pH of the environment has an effect on the effectiveness of AmF toothpastes. (Arnold et 
al., 2007) ran a pH cycling in vitro study to examine the effect of pH of amine fluoride 
containing toothpastes on enamel remineralisation. Results of their study demonstrated 
that lowering the pH of the environment during amine fluoride exposure had positive 
effects on enamel remineralisation in vitro. Furthermore the presence of fluoride at a pH 
between 4.5 and 5.1 caused the released mineral ions to be re-precipitated as mixed 
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fluor-hydroxyapatite enhancing remineralisation of the body of the lesion and the enamel 
surface layer. 
The current study also conflicts the results published by (Arnold et al., 2006) who 
compared the effect of four different toothpastes with differing fluoride compounds (AmF, 
NaF, MFP and F-Free) on enamel remineralisation. In their study the authors concluded 
that AmF produced the highest amount of remineralisation followed by MFP and lastly 
NaF. However, the results of their study are less than reliable due to the fact that the 
enamel slabs were immersed in the demineralisation solution for 50 days. This was then 
followed by incubation of the enamel slabs in toothpaste slurries for 48 hours, which 
according to the authors, simulates 2 years of tooth brushing. Unlike the current study, 
their methods did not represent the natural conditions of the oral environment, which 
include cycles of demineralisation and  remineralisation. 
(Patil and Anegundi, 2014) conducted a study with a methodology identical to (Arnold et 
al., 2006), and found supporting results. Again the issue with their study was that 
conditions did not match the oral environment. 
On the other hand, results of another in vitro pH cycling study (Casals et al., 2007) 
aiming to investigate remineralisation of human enamel after the use of commercially 
available toothpastes containing different fluoride compounds (NaF, SnF, MFP and 
AmF), concluded that NaF and SnF have superior remineralising potential on artificial 
subsurface carious lesions when compared to other fluoride compounds. The authors 
also concluded that NaF uptake into demineralised enamel in vitro was double the 
amount of AmF uptake at the same fluoride concentration. Their study  included 3 daily 
dippings of enamel slabs into a demineralising solution followed by 3 daily dippings into 
toothpaste slurries. This cycle was repeated for five days and is somewhat 
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representative of the continuous rise and fall of pH found in the oral environment. These 
results are harmonious with the results found in the current study. 
An in vitro pH cycling model demonstrated that NaF was statistically better at enamel 
remineralisation than MFP when lesions were assessed by cross sectional micro 
hardness (Toda and Featherstone, 2008). Also in line with results found in this current 
study, a recent in vitro experiment evaluating remineralisation of carious lesions and 
fluoride uptake by enamel exposed to various fluoride dentifrices, found that enamel 
remineralisation and fluoride uptake was significantly greater when using NaF compared 
to MFP. It was also concluded that efficacy of the fluoride dentifrice was dependant on 
ionic fluoride levels (Hattab, 2013). In both of these studies and as with most reports 
claiming the superiority of NaF against MFP, their claims were built on the assumption 
that fluoride only exerts its effects on demineralisation and remineralisation as a free ion. 
Unlike NaF (which releases free F-),  fluoride in MFP formulation is covalently bound to 
phosphate and requires enzymatic hydrolysis to release free F- (Pessan et al., 2011). 
This unfortunately is one of the limitations of in vitro pH cycling models due to the lack of 
enzymes in artificial saliva. 
When looking at clinical trials and in vivo experiments, a  Cochrane review by (Marinho 
et al., 2003) to determine the effectiveness and safety of ﬂuoride toothpastes in the 
prevention of caries in children, compared toothpastes containing MFP (22 trials), SnF 
(19 trials), NaF (10 trials) and AmF (5 trials) and did not find an link between the type of 
fluoride compound in the dentifrice and the magnitude of treatment effect. In spite of their 
findings the authors considered their results to be less reliable than evidence from head 
to head comparisons (Pessan et al., 2011). 
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4.10 Remineralising potential of toothpastes containing sodium 
fluoride (NaF) formulation at different concentrations of 
fluoride on artificial subsurface caries lesions in vitro. 
Phase B of the current study investigated the remineralising potential of toothpastes with  
different Fluoride (F) concentrations: 500, 1000, 1450, 2800, 5000 ppm F on artificial 
subsurface caries lesions in vitro. Non-fluoride toothpaste was used as a negative 
control. 
The study results demonstrated slight differences according to the parameter used: 
ΔF results: showed that there was statistically significant improvement in 
remineralisation between the baseline and after treatment for all groups. 
Remineralisation of the artificial subsurface carious lesions was highest, and almost 
identical in the 500, 1450, and  2800 ppm F groups. Followed by 5000 ppm, 1000 ppm 
and the lowest improvement was seen in the 0 ppm F group. 
When comparing the groups against each other, it can be seen that remineralisation of 
the 0 ppm F (Control) toothpaste group is significantly lower than remineralisation of all 
other test groups except for 1000 ppm F toothpaste. As for the remineralisation 
significance between different concentrations of NaF fluoride toothpaste, there was no 
significance when comparing any of the groups. 
ΔQ results: A statistically significant improvement in remineralisation between the 
baseline and after treatment was found in all groups. The highest improvement was 
achieved by the 1450  ppm F group followed by 2800 ppm F and the least improvement 
was seen in the 0 ppm F group (control). 
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When comparing the groups against each other, the remineralisation at baseline and 
after treatment in all test groups was statistically significantly higher than that for the 0 
ppm F group except for the 5000 ppm F group. No other statistical significance was 
found between groups. 
For the lesion area results: A significant reduction in the area of the white spot lesion 
was seen in all groups except for the 0 ppm F group. The highest reduction was found in 
the 1450 ppm F group followed by the 2800, 500, 1000, 5000 ppm F groups In 
descending order. 
When comparing the groups against each other, the difference in the lesion area at 
baseline and after treatment was statistically significant for the test groups compared 
with the 0 ppm F group. No significant difference was found between the test groups. 
As mentioned before, the ΔQ value was considered as the main indicator for the mineral 
loss and the lesion progression or regression in the present study. And therefore it 
seems as though in this current in vitro study design, there was no difference in the 
effect of toothpastes with sodium fluoride (NaF) formulation and different concentrations 
(500-5000 ppm F) on remineralisation of artificial subsurface carious lesions. 
Furthermore, no apparent dose response was present related to the concentration of 
fluoride.  
These results were unexpected and surprising as they contradict the results of a 
Cochrane review by (Walsh et al., 2010) that included 75 studies, indicating that the 
caries preventive effect of fluoride toothpaste increases significantly with higher fluoride 
concentrations. When compared to placebo. Concentrations of 450-550ppm F and 
below show no statistically significant effect, but a statistically significant effect was 
evident for 1000-1500 ppm F concentrations (prevented fraction: 25%) and for highest 
fluoride concentrations 2400-2800 ppm F (prevented fraction: 45%). However, the issue 
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with this review was, the conclusion that the efficacy of dentifrices containing 450-550 
ppm F is not significantly different from placebo was based only on two trials, while the 
number of studies comparing placebo with conventional concentrations 1000-1500 ppm 
F was significantly higher (58 trials). Furthermore, no conclusion could be taken when 
comparing the clinical efficacy of low fluoride and conventional toothpastes, as only one 
trial met the inclusion criteria of the systematic review. This clearly indicates that further 
research is needed prior to making the assumption that higher fluoride concentrations 
should always be preferred (Pessan et al., 2011) 
 Furthermore, Biesbrock et al. (2003a) conducted a randomised double-blind study to 
assess the anti-caries effectiveness of placebo, 500 ppm F and 1450ppm F dentifrices, 
and found a dose response depending on the concentration of fluoride used. The higher 
the dose used the lower DMF score at 9 and 21 months.  
Not all the evidence published in the literature supports the theory of a dose response to 
fluoride concentration toothpastes. A randomised controlled trial by Lima et al. (2008), 
evaluated the effect of low-fluoride dentifrice on children with different caries experience. 
One hundred and twenty 2 to 4 year old children, half with and half without active caries 
lesions were randomly divided into two groups which used either 500 ppm F or 1100 
ppm F dentifrices. The authors results pointed out that the anti-caries effect of the 500 
ppm F dentifrice was similar to the 1100 ppm F when used by caries inactive children. 
This supports the results found in the current study. However, a shortcoming of  the 
before mentioned trial was its short follow-up time (one year). 
Damato et al. (1990) carried out an in vitro pH-cycling experiment  to investigate the 
effect of fluoride concentration on enamel demineralisation and remineralisation. Artificial 
carious lesions were exposed to 0, 1, 250, 500, 1000, 1750, and 2500 ppm F toothpaste 
solutions in a pH cycling model. The authors determined that there was a cut-off point of 
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500 ppm F where any concentration below would not remineralise the artificially 
demineralised enamel lesions. Furthermore the authors also concluded that higher 
fluoride concentrations did not produce any further significant increase in 
remineralisation when compared to the 500 ppm F group. This is in line with results of 
the current study. 
The exact cause of why a dose response to different concentrations of NaF was not 
evident in the present study is difficult to explain, although speculations can be made. A 
possible explanation could be that an exceedingly high fluoride concentration toothpaste 
slurry produced a surface mineral rich layer which in turn compromised the 
remineralisation of the body of the lesion. In the literature there is evidence that the use 
of frequent applications of a low concentration of fluoride is preferable to the use of high 
fluoride concentration as the latter will cause rapid formation of an insoluble calcium 
fluoride precipitate on the surface layer of an incipient caries lesion. This will block the 
pores on the surface layer and prevent mineral re-precipitation into the subsurface body 
of the lesion arresting the process of remineralisation (ten Cate et al., 1981). 
Another possible speculation for the lack of a dose response in this current study could 
be that, in the in vitro situation, (unlike the in vivo environment) the concentration of 
fluoride in toothpaste has no effect on the amount of remineralisation of demineralised 
enamel, and that a minimal amount of free fluoride ions are necessary to produce 
sufficient remineralisation. 
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4.11 Suggestions for future research 
More research into the remineralising potential of different fluoride formulations and 
concentrations is needed. In the current in vitro study, artificial day and night time saliva 
was used as an alternative to natural human saliva. Future research may incorporate the 
use of human saliva to assess whether or not it has an effect on the action of the fluoride 
toothpastes, as human saliva contains enzymes that may aid in hydrolysis of some 
organic fluoride compounds including MFP. 
The average ΔF (percentage fluorescence loss with respect to the fluorescence of sound 
tooth tissue - Related to lesion depth) reading at baseline for all the enamel slabs was -
13.26 %. It would be interesting in the future, to see whether or not deeper baseline 
depths of the enamel lesions have an effect on the dose response to different fluoride 
concentrations. This poses the question, do deeper lesions require higher concentrations 
of fluoride to remineralise? 
The pH cycling model used in this current study had a duration of 28 days. It would be 
interesting to see the same study repeated, but with a longer period of cycling e.g. 60, 90 
and 120 days. Alternatively the sample size  could be increased and this may show a 
difference between groups. 
The pH of the acetic acid used for the demineralisatiion cycle for this study was 4.8. 
Looking at the results, it seems that all groups showed remineralisation of the artificial 
enamel lesion to a similar level. Future in vitro designs could use acetic acid at a pH of 
4.5 as this would create a harsher environment for the enamel lesions. In this harsher 
environment, different concentrations/ formulations of fluoride may perform at 
significantly different levels. 
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Another possible modification to this current study would be the use of transverse micro-
radiography for assessment of artificial caries lesions at baseline and after treatment with 
the fluoride toothpastes. 
Furthermore, due to the limitations of in vitro experiments, future in situ and in vivo 
studies investigating the remineralisation of enamel by different formulations and 
concentrations of fluoride toothpaste may provide information that is directly associated 
with the clinical use of toothpastes. 
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4.12 Null hypotheses outcome 
1. The null hypothesis “There is no difference in the effect of toothpastes containing 
different fluoride formulations:  AmF, MFP, NaF and SnF on remineralisation of 
artificial subsurface carious lesions in vitro.” can be rejected as significant 
differences were found in the enamel remineralisation between the test groups. 
 
2. The null hypothesis “There is no difference in the effect of toothpastes with 
sodium fluoride (NaF) formulation and different concentrations (500-5000 ppm F) 
on remineralisation of artificial subsurface carious lesions in vitro.” Can be 
accepted as no significant differences were found in the enamel remineralisation 
between the test groups.
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CONCLUSIONS 
From the results of phase A of this in vitro study, it can be concluded that: 
1. A statistically significant remineralisation of enamel subsurface lesions in 
comparison with the baseline was found in all groups except the AmF group. 
2. NaF toothpaste has the highest remineralising potential on artificial subsurface 
carious lesions in vitro, followed by SnF then MFP. 
3. AmF remineralising potential on artificial subsurface carious lesions in vitro is 
less than fluoride-free toothpaste. 
From the results of phase B of this in vitro study, it can be concluded that: 
1. A statistically significant remineralisation of enamel subsurface lesions in 
comparison with the baseline was found in all groups. 
2. There is no difference in the effect of toothpastes with sodium fluoride (NaF) 
formulation and different concentrations (500, 1000, 1450, 2800, and 5000 ppm 
F) on remineralisation of artificial subsurface carious lesions in vitro. 
3. No apparent dose response was present related to the concentration of fluoride. 
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Appendix 2: Normality tests for ΔF at baseline phase A 
 
Shapiro-Wilk and Kolmogorov-Smirnov Tests of Normality for ΔF at Baseline. 
 
 
Group 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
 
ΔF at 
baseline 
F Free .116 25 .200* .940 25 .146 
NaF .138 25 .200* .893 25 .013 
SnF .193 24 .200* .928 24 .088 
MFP .228 26 .001 .865 26 .003 
AmF .137 25 .200* .948 25 .225 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Appendix 3: Normality tests for ΔQ at baseline phase A 
 
Shapiro-Wilk and Kolmogorov-Smirnov Tests of Normality for ΔQ at Baseline. 
 
Group 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ΔQ  at 
baseline 
F Free 0.138 25 0.200* 0.957 25 0.286 
NaF 0.114 25 0.200* 0.943 25 0.177 
SnF 0.134 24 0.200* 0.957 24 0.385 
MFP 0.117 26 0.200* 0.977 26 0.806 
AmF 0.111 25 0.200* 0.953 25 0.286 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Appendix 4: Normality tests for area of the white spot lesion at 
baseline phase A 
 
Shapiro-Wilk and Kolmogorov-Smirnov Tests of Normality for Area at Baseline. 
 
Group 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Area  at 
baseline 
F Free 0.077 25 0.200* 0.987 25 0.982 
NaF 0.103 25 0.200* 0.952 25 0.278 
SnF 0.106 24 0.200* 0.972 24 0.722 
MFP 0.078 26 0.200* 0.991 26 0.997 
AmF 0.138 25 0.200* 0.956 25 0.339 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Appendix 5: Normality tests for ΔF at baseline phase B 
 
Shapiro-Wilk and Kolmogorov-Smirnov Tests of Normality for ΔF at Baseline. 
 
Group 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ΔF at 
baseline 
0 ppm 0.116 25 0.200* 0.940 25 0.146 
500 
ppm 
0.214 26 0.004 0.909 26 0.025* 
1000 
ppm 
0.153 26 0.120 0.928 26 0.071 
1450 
ppm 
0.138 25 0.200* 0.893 25 0.013* 
2800 
ppm 
0.129 26 0.200* 0.941 26 0.144 
5000 
ppm 
0.216 26 0.003 0.823 26 0.000* 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Appendix 6: Normality tests for ΔQ at baseline phase B 
 
Shapiro-Wilk and Kolmogorov-Smirnov Tests of Normality for ΔQ at Baseline. 
 
Group 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
ΔQ at 
baseline 
0 ppm .138 25 .200* .957 25 .365 
500 
ppm 
.087 26 .200* .972 26 .683 
1000 
ppm 
.119 26 .200* .953 26 .267 
1450 
ppm 
.114 25 .200* .943 25 .177 
2800 
ppm 
.159 26 .089 .938 26 .122 
5000 
ppm 
.142 26 .190 .941 26 .143 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
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Appendix 7:Normality tests for area of the white spot lesion at 
baseline phase B 
 
Shapiro-Wilk and Kolmogorov-Smirnov Tests of Normality for Area at Baseline. 
 
Group 
Kolmogorov-Smirnova Shapiro-Wilk 
Statistic df Sig. Statistic df Sig. 
Area  at 
baseline 
0 ppm .077 25 .200* .987 25 .982 
500 
ppm 
.134 26 .200* .939 26 .128 
1000 
ppm 
.153 26 .119 .932 26 .087 
1450 
ppm 
.103 25 .200* .952 25 .278 
2800 
ppm 
.110 26 .200* .984 26 .946 
5000 
ppm 
.161 26 .080 .917 26 .038 
*. This is a lower bound of the true significance. 
a. Lilliefors Significance Correction 
 
